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Organochlorine pesticides (OCs) are environmental toxicants with important links 
to human health. They have been found to activate signalling pathways within cells and 
thereby affect cell survival and proliferation. Receptor Activator of Nuclear Factor kB 
(RANK) ligand and its receptor RANK are crucial for mammary epithelial proliferation 
in pregnancy and have recently been linked to hormone induced breast cancers. The 
objectives of this study were to confirm the proliferative effects of an OC (endosulfan) on 
human MCF-7 breast cancer cells, identify activated intracellular signaling pathways and 
investigate changes in RANK and RANKL gene expression. This study showed that 
endosulfan has a stimulatory effect on human MCF-7 cell proliferation, which may be 
invoked through activated intracellular signaling pathways (JNK, ERK1/2 and p38). In 
addition, there was a down regulation of RANK and upregulation of RANKL gene 
expression suggesting endosulfan is capable of modulating both cellular behavior and 
gene expression.   
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1. – Introduction 
1.1. - Organochlorine pesticides 
1.1.1. - Organochlorines 
Organochlorine (OC) pesticides are organic compounds known to cause adverse 
effects to human health and the environment. Organochlorines are cyclic hydrocarbon 
compounds that contain between one and ten carbon atoms covalently bonded to a 
chlorine atom (Turusov et al., 2002). They exhibit low water solubility, high lipid 
solubility, remain persistent in the environment and have a high bioaccumulative capacity 
(Coats 1990). OC pesticides demonstrate weak estrogenic or antiestrogenic effects. They 
have been found to alter normal cellular behaviour by mimicking a hormone, blocking 
the binding of endogenous hormones or modifying the synthesis, metabolism, or 
transport of hormones (Soto et al., 1995). OC compounds may act as a tumor promoter 
through hormone-mediated effects (Hansen and Matsumura, 2001) and have been linked 
with several hormone-related cancers including breast cancer (Calle et al., 2002). Due to 
the nature of persistence in the environment, bioaccumulation in the food chain, and pos-
sible human health effects, the use of most of OC pesticides were banned during the 
1970s and 1980s. Despite the ban of these chemicals a few decades ago in several 
countries, measurable amounts of OC pesticides or their metabolites can still be found in 
human tissues (Cerrillo et al., 2005). Also, OC pesticides continue to be heavily used in 
some developing countries (Turusov et al., 2002). Therefore, the health effects of OC 











1.1.2. - Endosulfan description and use 
These pesticides can be divided into four groups: dichlorodiphenylethanes, 
cyclodienes, chlorinated benzenes and cyclohexanes. Endosulfan is a cyclodiene 
insecticide widely used throughout the world on crops like cotton, corn, coffee, tea and 
vegetables (Kidd and James, 1991) (Figure 1). It exists in two forms: alpha endosulfan 
(6,7,8,9,10,10-hexachloro-1,5,5a,6,9,9a-hexahydro-6,9-methano-2,3,4-
benzodioxathiepin-3-oxide) and beta endosulfan (6,9-methano-2,4,3-benzodioxathiepin-
6,7,8,9,10,10-hexachloro-1,5,5,6,9,9-hexahydro-3-oxide (Kidd and James, 1991). 
Endosulfan is applied as a mixture of alpha (α) and beta (β) isomers in the ratios 2:1 to 
 
Figure 1:  The structure of endosulfan (Ledirac et al., 2005)  
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7:3 in agriculture (Wan et al., 2005a). Endosulfan (α) and (β) are primarily converted into 
the diol form in water and the sulfate form in soil and sediment. The endosulfan sulfate 
and diol further break down to the ether, hydroxyl ether, lactone, and alcohol forms 
(Hose et al., 2003). Endosulfan sulfate is the breakdown product considered to be as toxic 
as the parent isomers (Leonard et al., 2001). The half-lives of endosulfan (α) and (β) in 
water are on the order of days to months, whereas endosulfan sulfate is on the order of 
weeks to years (Leonard et al., 2001; Wan et al., 2005a).  
 
1.1.3. - Endosulfan is persistent and bioaccumulates in the environment 
Endosulfan is a ubiquitous environmental contaminant and persistent to 
degradation processes in the environment. Environmental endosulfan contamination is 
widespread and has been found in soil, ground and surface waters, marine sediments, air, 
rainfall, snow, and plants (Kumari et al., 2007; Tuduri et al., 2006; Herbert et al., 2004; 
Schulz et al., 2004; Tariq et al., 2004). Heaviest use of endosulfan was found in southern 
and western portions of Ontario including Lambton, Kent, Elgin, Haldimand-Norfolk, 
Niagara, Durham, York, and Simcoe counties (Harris et al., 2000). It reaches surface 
waters as a result of direct deposition and runoff from agricultural use.  Aquatic animals 
periodically suffer from the lethal concentrations of endosulfan ranging from <0.01 mg/L 
to 0.54 mg/L in surface waters in southern Ontario (Harris et al., 2000). Endosulfan was 
found in both terrestrial and aquatic species in Greenland with significant 
bioaccumulation of endosulfan in tissue and biomagnification in wolfish and caplin 
(Vorkamp et al., 2007). The chemical is considered semi-volatile since 70% of 
endosulfan is able to volatilise within 2 days (Sutherland et al., 2004). Endosulfan is also 
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a ubiquitous air contaminant and regional atmospheric transport is prevalent within and 
into Ontario (Johnson et al., 1988). Both endosulfan (α) and (β) were detected in 
precipitation in northern portions of Lakes Ontario, Erie and Superior (Chan et al., 1994; 
Johnson et al., 1988). As well, high concentrations levels (5.71 ng/m
3 
) of endosulfan 
have been identified in Canada including Great Lakes Basin, the City of Toronto, the 
Fraser Valley of British Columbia, Prince Edward Island, Quebec, Ontario and 
Saskatchewan in 2003 (Yao et al., 2006).  
 Several European countries have banned the use of endosulfan and 
discontinuation of the use of endosulfan took effect in January 2011 in Canada (Health 
Canada).  Despite the discontinuation of the use of endosulfan in Canada, it still remains 
a serious environmental concern due to its persistence and slow degradation processes in 
the environment. Endosulfan is one of the main causes of poisoning in humans in many 
countries (Kishi et al., 2002; Oktay et al.,  2003; Roberts et al., 2004; Wesseling et al., 
2005). The highest concentration of endosulfan (α) and (β) was found in female adipose 
tissue  with a concentration of 17.72 ng/g lipid (Cerrillo et al., 2005, 2006; Ibarluzea et 
al., 2004; Hernandez et al., 2002), followed by breast milk with the concentration of 
11.38 mg/ml (Cerrillo et al., 2005; Campoy et al., 2001); placenta at 7.74ng/mL (Cerrillo 
et al., 2005); umbilical cord blood at 6.11ng/mL (Cerrillo et al.,  2005); and blood serum 
at 7.74 ng/mL (Vidal et al., 2002; Arrebola et al., 2001). Endosulfan diol was found in 
placenta with a mean concentration of 12.56 ng/mL and in blood at 13.23 ng/mL (Cerrillo 
et al., 2005). Endosulfan sulfate was found in placenta with a mean concentration of 
3.57ng/mL and in umbilical cord at 2.82 ng/mL (Cerrillo et al., 2005). This indicates that 
endosulfan can be easily transferred to the fetus and newly-born infant. The mean 
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concentration of endosulfan (α) was found to be 2.44 ng/mL in cord serum and the mean 
concentration of endosulfan (β) was found to be 2.83 ng/mL in humans (Mariscal-Arcas 
et al., 2010). Although aquatic organisms near agricultural areas are known to be exposed 
to the highest levels of endosulfan, the primary source of exposure to OC pesticides in the 
human population is by ingestion (from eating contaminated food), inhalation, absorption 
through skin, and through pest control operations both at home and in resort areas (Wan 
et al., 2005b; Hose et al., 2003; Toppari et al. 1996; Naqvi and Vaishnavi, 1993). Other 
sources of exposure include dust, air, and soil. 
 
1.1.4. - Endosulfan is highly toxic 
Endosulfan (α) and (β) are both considered to be highly toxic. Doses as low as 
35 mg/kg has been documented to cause death in humans (Abalis et al., 1986). The oral 
LD50 of endosulfan in rats was found to be 80 mg/kg, whereas the fish LC50 found in 
laboratory studies was 1 to 100 μg/L (Hose et al., 2003; Jonsson and Toledo, 1993). 
Endosulfan acts on the central nervous system as a non-competitive GABA antagonist 
causing inhibition of the gamma-aminobutyric acid (GABA)-gated chloride channels and 
uncontrolled excitation (Jia and Misra, 2007a). After exposure, acute symptoms such as 
hyperactivity, erratic swimming, and convulsions have been observed in adult fish 
(Jonsson and Toledo, 1993). It has also been hypothesized that endosulfan(α) causes 
inhibition of Ca+Mg-ATPase and Ca-ATPase activity (Coats, 1990; Srikanth et al., 
1989). Endosulfan targets the prefrontal cortex of the brain altering levels of the 
neurotransmitters dopamine, noradrenalin and serotonin and causing disruptions in 
cognitive functions and memory (Cabaleiro et al., 2008). Endosulfan is extremely toxic to 
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fish, especially to juveniles (Dutta and Arends, 2003). It is particularly neurotoxic during 
the developmental stages in fish and rodents causing alterations in neurotransmitter and 
amino acid measurements and making organisms more vulnerable to the adverse effects 
of chemicals (Cabaleiro et al., 2008; Rosenthal, 1976). Of direct relevance to human 
health, evidence suggests that endosulfan may even increase the risk of Parkinson‟s 
disease (Wang et al 2006a; Jia and Misra 2007b). 
Endosulfan induces immunotoxic and immunosuppressive effects in fish, rodents 
and humans. It causes suppression of phagocytic function of the immune cells of 
Australian freshwater fish (Harford et al., 2005). Female rats exposed to endosulfan in 
utero and through postnatal lactation displayed immunosuppression (Lafuente et al., 
2006). It also induces the apoptosis of human T-cells (Kannan et al., 2000).  
 
1.1.5. - Endosulfan causes reproductive and developmental defects 
Chronic neural damage may result in abnormal hormonal release, defects in 
synthesis and feedback mechanisms and even impaired gonadal development and other 
reproductive dysfunctions (Pandey 1988; Haider and Inbaraj 1988; Matthiessen et al., 
1984). Exposure to endosulfan during developmental phases has been shown to decrease 
fertility, reduce sperm count, cause degeneration of seminiferous tubule epithelium, 
increase abnormal sperm, and aspermatogenesis in rats (Saiyed et al., 2003; Sinha et al., 
2001; Dalsenter et al., 1999). Adverse reproductive outcomes such as reduced male 
fertility, neonatal deaths and congenital birth defects were also found in humans exposed 
to endosulfan (Rupa et al., 1991). Increased incidences of cryptorchidism have been 
observed in populations exposed to endosulfan (Ferrando et al., 1992). Reproductive 
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dysfunctions were also evident in fish due to bioaccumulation of endosulfan. The 
transgenerational effect was shown when fish eggs exposed to sublethal concentrations of 
endosulfan were delayed in hatching, had reduced hatchability and and upon reaching 
maturity, produced fewer eggs which took longer to hatch (Gormley and Teather, 2003). 
The transgenerational transfer of endosulfan was also shown when fertility and hatch 
rates were found to be significantly reduced in two subsequent generations of rainbow 
trout after parental exposure to endosulfan (Holdway et al., 2008). 
 
1.1.6. - Endosulfan is an endocrine disruptor 
Endosulfan has adverse endocrine-disrupting effects on humans (Scippo et al., 
2004). It has been found to evoke estrogenic responses in human breast cells by 
mimicking estrogen (Li et al., 2006) and interfering with the normal levels of estrogen 
receptors (Grunfeld & Bonefeld-Jorgensen 2004; Soto et al., 1995, 1994). Endosulfan is 
comprised of lipophillic phenolic rings and other hydrophobic components also found in 
steroid hormones necessary to activate the estrogen receptor (Watson et al., 2007). It has 
been shown to cause proliferation, transformation, differentiation and migration of human 
estrogen-sensitive breast cancer cells (Li et al., 2006; Bonefeld-Jorgensen et al., 2005; 
Soto et al., 1994; 1995), and estrogen-sensitive ovarian cells (Wong and Matsumara, 
2006). The simultaneous exposure of breast cancer cells to endosulfan and growth factors 
has resulted in cell growth (Cossette et al., 2002). Lemaire et al. (2006) proposed that 
endosulfan activates estrogen receptor (ER) α but weakly antagonises ERβ. This further 
enhances the proliferative effects of endosulfan because activation of ERβ is involved in 
attenuating cell proliferation. In addition to mimicking estrogenic responses, endosulfan 
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has also been found to be anti-androgenic (Chatterjee et al., 2008; Kojima et al., 2004; 
Andersen et al., 2002). It induces the activation and proliferation of progesterone 
receptors in human breast cancer cells (Hunter et al., 1999; Soto et al., 1995).  
 
1.1.7. - The role of endosulfan in cancer 
Exposure to endosulfan at very low concentrations may play a significant role in 
breast biology and breast cancer by causing alterations in hormonal mechanisms. Laville 
et al. (2006) found that endosulfan at low concentrations activates aromatase (an enzyme 
for catalyzing androgens into estrogen) in cancer cells further enhancing the estrogenic 
effect. MCF-7 breast cancer cells treated with endosulfan displayed significant increase 
in the ratio of 16-hydroxyestrone (a tumour promoting oestrogen) to 2-hydroxyestrone 
(non-genotoxic), amplifying cell proliferation (Bradlow et al., 1995). Endosulfan 
mimicks estrogen by building up cellular calcium levels, causing rapid secretion of 
prolactin and increasing cell proliferation (Watson et al., 2007; Wozniak et al., 2005; 
Rousseau et al., 2002) 
Hence, endosulfan is postulated to act as a promoter of tumour growth through 
hormone-mediated effects (Hansen and Matsumura, 2001). Endosulfan (α) has been 
found to be a tumour promoter in hepatocytes (Dubois et al., 1996; Warngard et al., 
1996; Fransson-Steen et al., 1992). Even though the evidence to classify endosulfan as 
carcinogenic is inconclusive, human epidemiologic and animal studies have shown that 
the exposure to OCs is positively correlated with several hormone-related cancers, 
including breast cancer (Calle et al., 2002), prostate cancer (Mills and Yang, 2003), 
endometrial cancer (Weiderpass et al., 2000), and testicular cancer (Biggs et al., 2008). 
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Elevated adipose tissue levels of endosulfan in women have been associated with an 
increased risk of breast cancer (Ibarluzea et al., 2004). Some studies have shown that 
exposure to endosulfan increases the total number of malignant tumours, pulmonary 
adenomas, carcinomas, hepatic carcinomas and sarcomas in female rats and 
lymphosarcomas in male rats (Reuber, 1981).  
 
1.2. - Organochlorines and Activation of the Mitogen-Activated 
Protein Kinase Kinase Signaling (MAPKK) Cascade 
 
1.2.1. - Mitogen-activated protein kinase kinase signaling (MAPKK) cascade 
Organochlorines have been found to activate intracellular signalling pathways 
independent and in conjunction with the estrogen receptor activation (Hatakeyama et al., 
2002) (Figure 2). Therefore, OCs can also cause the activation of mitogen-activated 
protein kinase kinase (MAPKK) signalling cascades ultimately altering cell behaviour 
(Ledirac et al., 2005). The MAPKK cascades are found in all eukaryotes. This pathway is 
comprised of three core enzymes that act in sequential phosphorylating steps: a MAP 
kinase kinase kinase (MAPKKK or Raf), a MAP kinase kinase (MAPKK or MEK), and a 
MAP kinase (MAPK or ERK) (English et al., 1999). MAPKs are important 
serine/threonine signal transducing enzymes connecting cell-surface receptors to critical 
regulatory targets responsible for altering gene expression within the cytoplasm and the 
nucleus of cells. Therefore, MAPK signalling cascades play a critical role in the control 




The MAP kinase signaling cascade responds to a wide variety of extracellular 
signals such as binding of growth factors/hormones or estrogen mimicking compounds 
(xenoestrogens) to a membrane receptor (reviewed by Karp 2010). The MAP kinase 
kinase cascade starts off by 
phosphorylating cytoplasmic components such as Raf. Raf is a serine-threonine protein 
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MAPKK. MAPKKs are dual specificity kinases since they can phosphorylate tyrosine as 
well as serine and threonine residues (Shen et al., 2001). All MAPKs have a tripeptide 
near their catalytic site with the sequence Thr-X-Tyr. MAPK activates two MAP kinases 
named ERK1 and ERK2 via phosphorylation of both the threonine and tyrosine residues 
(Schramek, 2002). Phosphorylated ERK1/ERK2 have been found to activate a number of 
nuclear transcription factors and other nuclear proteins. This pathway activates cyclin D1, 
which plays a key role in driving a cell from G1 into S phase, and eventually causes 
activation of genes involved in cell proliferation (reviewed by Karp 2010).  
Mammals express four distinctly regulated MAPKK subfamilies: extracellular 
signal-related kinases (ERK1/2), Jun amino-terminal kinases (JNK1/2/3), p38 MAPK 
(p38α/β/γ/δ), and ERK5 (Gutkind, 2000).  
1.2.2. – Extracellular signal-related kinases (ERK1/2) 
The ERK1/2 group is activated mainly by mitogenic stimuli, and it has been 
linked to cell survival. ERK1/2 stimulates DNA synthesis through phosphorylation of a 
rate-limiting enzyme in pyrimidine nucleotide biosynthesis (Graves et al., 2000). ERKs 
also promote cell-cycle progression by inactivating a cell-cycle inhibitory kinase (Palmet 
et al., 1998) and ERKs can stimulate cell proliferation by indirectly inducing cyclin D1 
(Treinies et al., 1999). ERK may also induce growth factors that promote cell survival 
and ERK1 deficient mice (Erk1
-/-
) have defective T-cell development (Pages et al., 





1.2.3. - C-Jun amino-terminal kinases (JNK1/2/3) and p38 mitogen- activated 
protein kinase 
The activation of JNK and p38 MAPK pathways is primarily caused by stress 
stimuli such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock. They are 
linked to the induction of cell differentiation and apoptosis (Xia et al., 1995). Both JNK1 
and JNK2 are required to induce the apoptosis of ultraviolet-irradiated fibroblasts 
(Tournier et al., 2000). Importantly, induction of apoptosis did not occur in JNK deficient 
(JNK3
-/-
 ) mice (Yang et al., 1997);  while the JNK1 deficient ((JNK1
-/-
) mice exhibited 
defective T-cell differentiation to T-helper cell type-2 (Th2 cells) (Dong et al., 1998), 
JNK2 deficient ((JNK2
-/-
) mice exhibited defective T-cell differentiation to T-helper cell 
type-1 (Th1 cells) (Yang et al., 1998). Therefore, the JNK signalling pathway is 
important in T cell differentiation, regulating inflammatory responses and cellular 
apoptosis in mammals.  
According to one study, p38α MAPK deficiency resulted in lethality in mice 
before day 11 of gestation due to defective placental developments (Adams et al., 2000). 
In additon, p38α deficient mice show low kidney production of the hormone 
erythropoietin and subsequently insufficient red blood cell production (Tamura et al., 
2000). Hence, these studies underscore the importance of p38 MAPK in normal cell 
biology.  
 
1.2.4. - Organochlorines activate MAPKK signaling cascades 
Organochlorines have been found to activate MAPKK signaling pathways 
causing abnormal cell proliferation and tumorigenesis (Okoumassoun et al., 2003). An 
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organochlorine, heptachlor, which is structurally similar to endosulfan has been found to 
trigger significant proliferation in rat hepatocytes by the induction of ERK 
phosphorylation and inhibition of apoptosis (Okoumassoun et al., 2003). Heptachlor has 
also been shown to increase phosphorylation of ERK1/2 in human lymphocytic cells 
(Chuang and Chuang, 1998). Hence it is reasonable to postulate that endosulfan will also 
activate MAPKK signalling pathways in other human cells and alter gene expression.  
RANKL and its receptor RANK play a crucial role in controlling the development 
of lactating mammary glands during pregnancy (Fata et al., 2000). In addition, induction 
of RANKL gene after stimulation with hormones increased proliferation in mammary 
epithelium (Beleut et al., 2010). Since OCs alter normal cellular behaviour by mimicking 
a hormone (Soto et al. 1995) and induce proliferation and differentiation of human breast 
cancer cells (Soto et al 1994, 1995; Bonefeld-Jorgensen et al., 2005; Li et al., 2006), 
stimulation with OCs may lead to changes in RANK and RANKL gene expression in 

























Figure 3: Exposure to organochlorines may alter RANK & RANKL mRNA expression 
in human breast cells. 
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LIGAND SIGNALING AXIS  
 
1.3.1 - RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B  
The Receptor Activator of Nuclear Factor kappa B (RANK), also known as 
TRANCE receptor is a member of the tumor necrosis factor (TNF) cell surface receptor 
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transcription factor Nuclear Factor Kappa-B (NF – kB) and activator protein-1 (Anderson 
et al., 1997; Ross, 2000). Therefore, it controls transcription of its target genes via an 
intracellular cascade of signals (Wei et al., 2001; Cao et al., 2001). The RANK 
transmembrane receptor protein is comprised of 616 amino acid residues, of which 383 
amino acids reside in the intracellular domain. RANK mRNA is ubiquitously expressed 
in human tissues including dendritic cells, T cells, fibroblasts (Anderson et al., 1997) and 
mammary epithelial cells (Srivastava et al., 2003).  
1.3.2 - RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B LIGAND  
RANKL is a member of the TNF cytokine superfamily that exists in both soluble 
and membrane-bound forms (Lasey et al., 1998; Yasuda et al., 1998). RANKL is a type 
II transmembrane protein consisting of 317 amino acid residues, and is found on the 
surface of stromal cells, osteoblasts and activated T cells (Simonet et al., 1997; Anderson 
et al., 1997). RANKL is expressed as an osteoclast differentiation factor (Yasuda et al., 
1998), as an apoptosis regulatory protein (Wong et al., 1997), and as a ligand for the 
soluble TNFR family member osteoprotegerin (Lacey at al., 1998). RANKL binding to 
RANK causes RANK to interact with TNF-receptor associated factors (TRAFs) such as 
TRAF2, TRAF3, TRAF5, and TRAF6 initiating a cascade of kinases. RANKL binding to 
RANK activates osteoclast maturation (Wei et al., 2001). The RANKL gene is found on 
the human chromosome 13q14 (Anderson et al., 1997). The RANKL gene exists in three 
RANKL isoforms: hRANKL1, hRANKL2, and hRANKL3. The hRANKL1 isoform is a 
45 kDa membrane- associated protein comprised of intracellular, transmembrane and 
extracellular domains and spans approximately 36 kb of genomic DNA with six exons. 
Whereas, the hRANKL2 form is a 31 kDa soluble protein lacking the N-terminus 
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intracellular domain and the hRANKL3 isoform is a 39.5 kDa soluble protein lacking 
both the intracellular and transmembrane domains (Suzuki et al., 2004).   
 
1.4. - Functions of the RANK/RANKL Pathway 
 
 
1.4.1. - Role in bone remodeling and bone disease 
The RANK/RANKL pathway is a key regulator of bone metabolism through its 
effects on development and activation of osteoclasts. Bone growth and remodeling is a 
tightly regulated and a dynamic process. Bone matrix is synthesized by osteoblasts while 
resorption of bone occurs by multinucleated osteoclasts (Kong et al. 1999a; Takahashi et 
al., 1999).  
The process of osteoclast maturation and bone resorption is regulated by three 
main factors: RANKL, downstream signaling receptor for RANKL (RANK) and a decoy 
receptor osteoprotegerin (OPG) (Kong et al., 1999b; Lacey et al., 1998; Yasuda et al., 
1998; Wong et al., 1997). RANK is expressed by multinucleated osteoclasts (Burgess et 
al., 1999). RANKL mRNA is expressed by bone osteoblasts (Simonet et al., 1997). 
RANKL binds specifically to the RANK receptor on osteoclast or osteoclast precursor 
cells and causes activation and maturation of osteoclasts (Yasuda et al., 1998; Lacey et al., 
1998) and inhibition of osteoclast apoptosis (Fuller et al., 1998). RANKL expression is 
upregulated by many soluble factors affecting bone resorption, including the 
proinflammatory cytokines, interleukin-1 and TNF-(Hofbauer et al ., 1999; Martin et 
al., 1998). RANKL can also be cleaved by metalloproteinases into a soluble form 
(Nakashima et al., 2000). The RANK/RANKL causes activation of NF-κB, which is a 
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transcriptional regulator present in mammalian cells. It plays an important role in the 
regulation of genes involved in apoptosis, cell cycle control, immune responses and many 
other cell events (Dolcet et al., 2005; Cao et al., 2001). RANKL binds to the RANK 
receptor ultimately causing activation of the catalytic subunit IKKα and subsequent 
activation of NF-κB is involved in modulating normal cell cycle progression (Cao et al., 
2001). Although the exact mechanism of this transduction pathway is not fully elucidated, 
it is nevertheless believed to be important in regulating osteoclasts and osteoclast 
precursor cells.  
The natural decoy receptor of RANKL, OPG, is a RANK homolog that works by 
binding to RANKL on osteoblast/stromal cells, thus inhibiting RANK/RANKL 
interaction and osteoclast activity (Figure 4). Knockout studies in mice have been the 
major contributor to knowledge about the functions of the RANK/RANKL pathway in 
bone. RANKL -/- mice have been shown to suffer osteopetrosis, stunted growth and a 
defect in tooth eruption due to failed osteoclast development. The study concluded that 
RANKL deficient osteoblasts were not able to support normal osteoclastogenesis, and 
therefore mice showed decreased osteoclast production and severely impaired bone 
remodeling. However, administration of OPG dramatically reduced the bone loss 
mediated by RANKL (Kong et al., 1999a) and effectively inhibited osteoclastogenesis 
both in vitro and in vivo (Simonet et al., 1997). Thus RANKL levels must be regulated 
simultaneously with OPG levels, as the balance of the two will determine whether 






Figure 4: Activation of osteoclasts through RANKL binding to the RANK receptor 
causing bone resorption. OPG binds to RANKL and inhibits osteoclast activity. 
 
1.4.2. - Role in immunology  
The cell surface membrane bound RANKL is made and expressed by activated T 
cells and functions as an osteoclast differentiation factor (Hofbauer et al., 1999; Martin et 
al., 1998). RANKL knockout mice are immuno-compromised with inadequate 
development of lymph nodes and lack Peyer‟s patches (Kong et al., 1999b). RANK and 
RANKL are also expressed on B cells and dendritic cells. RANKL has been identified as 
a crucial factor involved in T cell–dendritic cell interactions and in dendritic cell survival 
(Bachmann et al., 1999; Anderson et al., 1997). RANKL is not only expressed on 
activated T cells but T cell-derived RANKL appears to be a link between inflammation 
and bone loss (Figure 5). T cell-derived RANKL regulates the development and 
activation of osteoclasts resulting in bone loss (Kong et al., 1999a) and T cells from 
inflamed joints also express RANKL. Increased expression of RANKL due to chronic 
systemic activation of T cells appears to play a prominent role in viral infections, 
autoimmune diseases or chronic local inflammation involving bone and joints such as in 
arthritis (Nakashima et al., 2003). Proinflammatory cytokines that stimulate 
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osteoclastogenesis such as IL-1ß, IL-6, IL-11, IL-17, and TNF-upregulate the 
expression of RANKL and downregulate RANK expression. On the other hand, 
cytokines that inhibit osteoclastogenesis, such as IL-13, interferon-, and transforming 
growth factor (TGF)-ß1 increase the expression of RANKL but decrease the expression 
of its inhibitor OPG (Nakashima et al., 2000). The wide use of corticosteroids to treat 
multisystem autoimmune disease and arthritis have resulted in bone loss since they have  
been found to strongly induce RANKL expression and decrease expression of its decoy 
receptor, OPG (Yasuda et al., 1998; Vidal et al., 1998).  
Synovial tissue from patients with rheumatoid arthritis and osteoarthritis has been 
shown to express high levels of RANKL (Kong et al., 1999a). High levels of RANKL 
were also found in affected synovial tissue of patients with spondyloarthropathies 
(Haynes et al., 2003). Co-culturing activated CD4+T cells and bone marrow cells 
resulted in the induction of osteoclastogenesis. This effect was blocked by the addition of 
OPG. Soluble RANKL produced by T lymphocytes also activated functional osteoclasts 
and once again administration of OPG was shown to protect both cartilage and bone in 
rats with adjuvant-induced arthritis. Therefore, administration of OPG in animal models 





Figure 5: Activation of osteoclasts by binding of RANKL on activated T cells to RANK 
on dendritic cells indicating a link between activated T lymphocytes and 
osteoclastogenesis. 
 
1.4.3. - Role in lactating mammary gland development 
Along with the significance of RANK/RANKL signaling pathway in the 
regulation of osteoclastogenesis and the immune system, it is essential in the 
morphogenesis of the lactating mammary gland. RANK and RANKL signaling axis is 
crucial for the formation of the lobulo-alveolar structures during pregnancy (Fata et al., 
2000). Expression of RANKL is not only restricted to lymphocytes, monocytes, 
macrophages, dendritic cells, and synovial fibroblasts but it is also found on mammary 
epithelial cells of pregnant and lactating females (Theill et al., 2002; Kotake et al., 2001; 
Kong et al., 1999b). RANKL deficient mice not only exhibited defects in early 
differentiation of T and B lymphocytes and showed lack of active osteoclasts, but also 
failed to form the lobulo-alveolar mammary structures during pregnancy and displayed 
increased apoptosis of mammary epithelium (Fata et al., 2000).  
1.4.3.1. - Development and structure of the mammary gland 
The human mammary gland undergoes many stages of development, growth and 
differentiation. These stages include embryonic, prepubertal, pubertal, pregnancy, 
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lactation and involution. The ectoderm forms the epithelial layer of the gland, while 
mesoderm forms the surrounding stroma during the embryonic stages (Shackleton et al., 
2006). Mammary stem cells are activated during the developmental periods of puberty 
and pregnancy (Harmes and DiRenzo, 2009; Shackleton et al., 2006; Smith, 2005). The 
epithelial cells of the mammary gland develop into a branched ductal system during 
puberty. The collecting duct branches into smaller ductules, eventually terminating into 
ductal-lobular units or lobules that develop mainly during pregnancy. These lobules 
consist of alveoli, which are the actual secretory units that produce milk during the 
lactation stage. The lobulo-alveolar compartment develops and undergoes functional 
differentiation during pregnancy in response to reproductive hormones such as 
progesterone and prolactin (reviewed by Henninghausen and Robinson, 2001). 
1.4.3.2. - Steroid hormones control ductal and alveolar development 
Women are repeatedly exposed to ovarian hormones during the reproductive 
lifespan (Bernstein, 2002; Apter et al., 1989; Trichopoulos et al., 1972). Mammary gland 
development becomes hormone dependent at the onset of puberty. Estrogen and 
progesterone are primarily known to play a significant role in mediating signaling 
processes in the development of the mammary gland and the reproductive system. Steroid 
hormones function via binding to the specific nuclear receptors and activating genes in a 
ligand dependent manner. Estrogen receptors and progesterone receptors are found at 
high levels in mammary glands. Progesterone receptor deficient mice have an inability to 
ovulate and have severely limited mammary gland development (Henninghausen and 
Robinson, 2001). A recent study has shown that mammary stem cells increase 14-fold 
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during the luteal diestrus phase of the menstrual cycle in mice when the progesterone 
levels are the highest (Joshi et al., 2010).  
 
1.4.4. - Proliferation of mammary gland cells through activation of the osteoclast 
differentiation factor RANKL 
Along with the systemic hormones, the osteoclast differentiation factor, RANKL, 
plays a crucial role in mammary development. Recent studies demonstrating the new role 
of RANK/RANKL pathway in lobular-alveolar development emerged from the study of 
mice lacking these proteins through genetic ablation. Fata et al. (2000) uncovered the role 
of RANKL and its receptor RANK in controlling the development of lactating mammary 
glands during pregnancy. RANK was found to be constitutively expressed in normal 
mammary gland epithelial cells in mice, however RANKL expression was induced by 
sex hormones after day 12.5 of pregnancy. RANK and RANKL deficient mice displayed 
reduced pregnancy-induced proliferation and differentiation of the alveolar buds into 
functional mammary glands. These mice lacked lactating mammary glands and were 
unable to feed their offspring (Hofbauer et al., 2008; Fata et al., 2000). Administration of 
recombinant RANKL induced lobulo-alveolar development in mice by stimulating 
proliferation of alveolar bud epithelia and restored milk production.  
Earlier studies showed that signal transducer and activator of transcription 5a 
(Stat5a) protein is involved in the development of mammary gland. Phosphorylation of 
Stat5a and Stat5b proteins was found to be very low in mammary tissue of virgin mice, 
however a drastic increase was observed in pregnant mice (Lui et al., 1996). Stat5a was 
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also known for its major role in the expression of the milk-secreting proteins by 
regulating gene expression (Liu et al., 1997).  RANKL upregulation during pregnancy 
and lactation was shown to be under the control of Stat5a activation by prolactin 
stimulation (Srivastava et al., 2003). In addition, it is also postulated that Stat5a 
activation regulates genes involved in proliferation and cell cycle progression. 
 
1.4.5. - Steroid hormones in the development of breast cancer through induction of 
RANKL 
 
Breast cancer is one of the most common cancers in humans, affecting 
approximately 207, 090 women in the United States every year (Jemal et al., 2010). As 
mentioned earlier, women are repeatedly exposed to ovarian hormones during the 
reproductive lifespan; the higher number of menstrual cycles also correlates with 
increased risk of developing breast cancer (Bernstein, 2002; Apter et al., 1989; 
Trichopoulos et al., 1972). Hormone replacement therapy has been positively correlated 
with an increased risk and incidence of breast cancer (Rossouw et al., 2002; Beral et al., 
2003).   
Hormones and hormone derivatives have been shown to increase RANKL 
expression in the breast (Gonzalez-Suarez et al., 2010; Schramek et al., 2010). Synthetic 
progesterone derivatives (progestins) such as medroxyprogesterone acetate (MPA) used 
for hormone replacement therapy and contraceptives significantly increased the risk of 
developing breast cancer in mice (Schramek et al., 2010). Stimulation of luminal cells 
with progesterone increased RANKL expression by several thousand-fold (Joshi et al., 
2010). In addition, in vivo administration of medroxyprogesterone (MPA) triggered 
massive induction of RANKL in mouse mammary gland epithelial cells (Schramek et al., 
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2010). Induction of RANKL after stimulation with progesterone increased proliferation 
in mammary epithelium during mammary gland lactational morphogenesis (Beleut et al., 
2010). However, when RANK is genetically inactivated in these mammary gland 
epithelial cells, epithelial proliferation is attenuated and cells are driven towards 
preprogrammed apoptosis (Schramek et al., 2010).  
The notion that the downstream mediator of progesterone is RANKL was further 
validated when progesterone stimulated luminal cells of breast ducts to increase RANKL 
expression by several thousand-fold (Joshi et al., 2010). Progesterone seems to play a 
prominent role in the expansion of mammary stem cells during the reproductive cycles, 
where mammary stem cells may be the seeds that accumulate mutagenic hits, possibly 
leading to breast cancer (Joshi et al., 2010).  
Additionally, the activation of RANK/RANKL signaling pathway in the absence 
of hormones can also induce proliferation of mammary epithelial cells (Fernandez-
Valdivia et al., 2010; Gonzalez-Suarez et al., 2010). Mouse mammary tumour virus-
RANK transgenic mice exhibited accelerated epithelial cell growth (pre-neoplasias) and 
increased mammary tumour formation after treatment with a carcinogen, 7, 12-
dimethylbenzanthracene, or progesterone derivative medroxyprogesterone acetate 
(MPA). Cyclin D1 expression has been proven to be involved in mammary gland 
development and breast carcinogenesis (Yu et al., 2001) and has been shown to be 
induced by NF-κB signaling pathway activated by RANK/RANKL binding (Guttridge et 
al., 1999). RANKL inhibition reduced mammary epithelial proliferation and cyclin D1 
levels caused by stimulation with hormone or carcinogen and subsequently attenuated the 
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mammary tumour development in wild-type mice and hormone treated mouse mammary 
tumour virus-RANK (mmtv- RANK) transgenic mice (Gonzalez-Suarez et al., 2010). 
This links the RANK/RANKL signaling pathway to mammary tumorigenesis and 
illustrates the potential role of RANK and RANKL inhibition in mediating breast cancer.   
 
Although regulation of RANKL expression in the breast by the hormones 
prolactin and progesterone has been reported to occur through Stat5a activation, no 
current data exists on how other signalling pathways may contribute to the regulation of 
its expression.  RANKL upregulation has been reported through MAPK pathways in 
osteoblasts (Zhou et al., 2010), but no research on how MAPK pathways in breast cancer 
cells may regulate RANK/RANKL gene expression has been reported.  
 
 
1.4.6. - RANKL inhibition prevents bone metastasis 
If mammary stem cells may be the „seeds‟ that accumulate mutagenic hits that 
could lead to breast cancer (Joshi et al., 2010), then Stephen Paget (1889) was the first to 
propose that bone microenvironment provides an especially fertile „soil‟  for seeding 
circulating cancer cells. Bone is the most common site of metastatic invasion in breast 
cancer (Lau et al., 2009; Mundy, 2002; Sloan and Anderson, 2002; Chambers et al., 
2000). Approximately 80% of patients with advanced breast cancer suffer from bone 
metastasis (Lau et al., 2009). Jones et al. (2006) observed that RANKL induces the 
migration of various RANK expressing human breast cancer cell lines including MDA-
MB-231, Hs578T and MCF-7. However, addition of RANKL inhibitors such as OPG 
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caused reduction in RANKL-induced migration of cells (Jones et al., 2006). Blockade of 
RANK/RANKL signalling was found to slow down metastasis of breast cancer to bone 
(Canon et al., 2008). Inhibition of this pathway by OPG administration reduced the 
skeletal tumour burden by 50% (Jones et al., 2006) and 75% (Morony et al., 2001) and 
prevented tumour-induced paralysis (Jones et al., 2006) in mice.  
The inhibition of RANK/RANKL pathway seems to be a potential target for 
therapeutic intervention in bone-related diseases. An inhibitor of the RANK/RANKL 
signalling pathway, Denosumab, was developed with high affinity for RANKL (Pageau, 
2009). It is a fully human monoclonal antibody to RANKL which prevents the binding of 
RANKL to its receptor RANK and thereby prevents bone resorption both in vitro and in 
vivo (Gerstenfeld et al., 2009). It is effectively used in the treatment of osteoporosis 
induced bone loss, bone metastases, rheumatoid arthritis and multiple myeloma and giant 
cell tumor of bone (Ellis et al., 2008; McClung, 2006) and has completed clinical trials 
for the management of skeletal related events in women with breast cancer (Stopeck et 
al., 2010). 
 
1.5. - Human MCF-7 Breast Cancer Cells Used in this Study 
 An In vitro model was used to study cancer cells behaviour as it allows for a 
detailed analysis at the cellular and molecular levels. Cell culture allows for an in depth 
and controlled study of behavioural responses, stimulation of molecular signaling and 
pathways and changes in gene expression in human cells. This study used human MCF-7 
breast cancer cells; human breast epithelial adenocarcinoma cells derived from a pleural 
effusion from a breast cancer patient. MCF-7 cells retain several characteristics of 
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differentiated breast epithelium and are known to contain high amount of estrogen 
receptors (Brooks et al., 1973). They also contain high levels of prolactin receptors and 
progesterone receptors.   
 
1.6. - Research Objectives 
Organochlorine pesticides (OCs), such as endosulfan, are organic compounds that 
persist in the environment, bioaccumulate through the food chain, and pose a risk of 
causing adverse effects to human health and the environment by evoking estrogenic 
responses (Soto et al., 2005; Coats, 1990). Xenoestrogens have been found to activate 
intracellular signalling pathways independent and in conjunction with estrogen receptor 
activation (Hatakeyama et al., 2002; Hatakeyama et al., 2003) causing changes in gene 
expression levels and ultimately altering cell behaviour. The objectives of the study were 
to confirm the proliferative effects of organochlorine pesticide (endosulfan) on human 
MCF-7 breast cancer cells, identify activated intracellular signaling pathways and 
investigate changes in specific gene expression profiles.  Since organochlorines have 
been found to stimulate intracellular signalling, the mitogen-activated protein kinase 
kinase (MAPKK) pathway, and in particular three major arms of this pathway, ERK1/2, 
JNK and p38 MAPK, were studied. Activation of these signalling pathways is crucial for 
changes in gene expression that alter cellular behaviour (Chang and Karin, 2001). 
Therefore, the effects of endosulfan on the Receptor Activator of Nuclear Factor kB 
(RANK) and RANKL gene expression were examined. RANK ligand and its receptor 
RANK are crucial for mammary epithelial proliferation in pregnancy (Fata et al., 2000) 
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and also found to be associated with hormone mediated breast cancers (Schramek et al., 






















2. – Materials and Methods 
2.1. - Growth of Cell Lines 
Human MCF-7 breast cancer (MCF-7) cells were purchased from American Type 
Culture Collection (ATCC) and maintained in Minimal Essential Media (MEM) 
containing Earle‟s salts and 2mM L-glutamine (ATCC) supplemented with 10% fetal 
bovine serum (FBS) (Hyclone) and 0.1% penicillin/streptomycin (p/s) (Hyclone). These 
cells were incubated at 37º C in a water jacketed incubator (Fisher) in 5% CO2. Human 
intestinal epithelial (HT-29) cells (kind gift of Dr. J. Green-Johnson) were maintained in 
RPMI-1640 medium (Hyclone) supplemented with 10% FBS and 0.1% p/s at 37º C in 
5% CO2.  
 Both of these cells lines were adherent cultures grown in 75 cm
2
 Sarstedt cell 
culture flasks with 20 mL of culture media. Media was replaced every two days and cells 
were passaged after 70-75% confluency was reached. Cells were usually passaged every 
5-7 days. In order to passage the cells, media was aspirated and the cells were washed 
three times with 1X PBS. About 2mL 0.5% Trypsin/EDTA (Hyclone) was added to the 
75cm
2 
flask and incubated for 2 minutes at 37ºC until the cells were detached from the 
bottom of the plate. Cells were rinsed with 10 mL of cell culture media and placed in a 50 
mL polystyrene tube (Benton Dickinson). Cells were centrifuged at 1200 x g for 5 
minutes and the pellet was resuspended in 5 mL of media. One hundred µL of media 
suspension containing cells was stained with ½ dilution of trypan-blue (MP Biomedicals, 
Inc) and counted using a haemocytometer. After counting, about 1 million cells were 
added to each new flask. In order to freeze the cells, about 9 million cells were added to 
100 µL DMSO (Sigma) and 300 µL FBS in cryovials (Fisher Scientific). First they were 
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placed in a Nalgene “Mr.Frosty” Cryo container at -80º C overnight and then transferred 
to liquid nitrogen.   
2.2. - Stimulation of MCF-7 cells with Endosulfan 
A stock solution of 10 mM endosulfan (Sigma, Product Number: PST-501) was 
prepared by dissolving in DMSO. The compound was further diluted in MEM media with 
10% charcoal dextran-stripped fetal bovine serum (FBS, Fisher) to nominal 
concentrations of 1µm and 0.1 µm.  Cells were stimulated for up to 3 days before cell 
counting or RNA isolation and for 30 minutes or 45 minutes prior to protein isolation for 
MAPK phosphorylation detection. 
 
2.3 - Proliferation of MCF-7 cells in the Presence of Endosulfan was 
Tested Using Flow Cytometry (Millipore’s Guava Instrument) 
Proliferation in the presence of endosulfan was measured using Millipore‟s Guava 
(flow cytometer) instrument that counts cell viability. It is a technique used for counting 
and examining cells by suspending them in a stream of fluid and passing them through 
the electronic detectors. A beam of light of a single wavelength is directed onto a 
hydrodynamically-focused stream of fluid containing cells. Each viable suspended cell 
passing through the beam scatters the ray and emits fluorescent light (cells are incubated 
in a reagent containing fluorescent dye prior to counting). This fluorescent light is picked 
up by the detectors and generates viable cell count. For experimentation, cells were 




flasks (Sarstedt) with 5 mL of charcoal dextran-stripped media and incubated at 37⁰ C in 
5% CO2.  After 24 hours, the media was removed and cells were exposed with 1 µM 
endosulfan or 0.1 µM endosulfan diluted in the appropriate media. This experiment 
comprised of two control conditions. The cells in the negative control flask were 
stimulated with 0.1% DMSO diluted in the media since this was the calculated 
percentage of DMSO found in the diluted concentration of 1 µM endosulfan. The cells in 
the control condition were incubated in just MEM media with charcoal dextran-stripped 
(FBS). Initially, 300 000 cells were plated in 12 flasks (4 flasks for each day). Media was 
not removed or changed from the flasks until the cells were extracted to measure cell 
growth. The cell growth was observed over 3 days.  
 
2.3.1. - Preparing the cell suspension with Guava ViaCount reagent and generating 
absolute cell count and viability 
The Guava ViaCount assay was used to distinguish between the viable and non-
viable cells based on the differential permeability of DNA-binding dyes in the ViaCount 
Reagent. The Guava ViaCount Reagent was purchased from the Guava Technologies. 
Cells from each flask were detached using trypsin and re-suspended in 5 mL of media 
(cells + trypsin + 5 mL of media = original cell suspension). The original cell suspension 
was diluted by a factor of 10. Fifty µL of that original cell suspension volume was 
transferred to 1 mL tube along with 450 µL of the Guava ViaCount reagent.  The solution 
was vortexed for 5 minutes and the absolute cell count and viability measurements was 
generated using the Guava instrument. The entire endosulfan stimulation experiment was 
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repeated three times and a graph was generated. SigmaPlot was used to generate linear 
regressions and used to generate p values using a student‟s T-test.  
2.4 - Protein Analysis 
2.4.1 - Protein isolation 
For experimentation, 1 million cells were plated in three 25 cm
2 
flasks with 5 mL 
of charcoal dextran- stripped media and incubated at 37⁰ C in 5% CO2. One flask 
comprised of the control condition, while the remaining two flasks were stimulated with 
0.1 µM endosulfan in MEM media. The lysis reagent in Pro-Q Diamond Phosphoprotein 
Enrichment Kit (Invitrogen) was used for the isolation of protein from the MCF-7 cells. 
About 1 million cells were harvested and lysed with 500 µL of lysis reagent along with 
endonuclease and protease inhibitor (Applied Biosystems). After lysis, a cell pellet was 
obtained through centrifugation at 15 000 g in a table top microfuge (Thermo Scientific) 
for protein and was extracted after 30 minutes and 45 minutes.  
The pellet was resuspended in the lysis reagent until the pellet was completely 
dissolved and incubated for 30 minutes on ice. The cell lysate was centrifuged at +4 
degrees Celsius for 30 minutes at 15,000 g. The supernatant cytoplasmic lysate was 
retained and unphosphorylated proteins were quantified using the Bradford Assay.  
In order to isolate phosphorylated proteins, the cytoplasmic lysate was loaded 
onto a column containing a phosphoprotein-binding resin and the phopho proteins were 
subsequently eluted using the elution buffer. The sample was concentrated using Tris and 
CHAPS in the Vivaspin filtration concentrator provided in the kit. To ensure maximum 
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recovery of protein, the sample was precipitated using the methanol-chloroform-water 
method. About 600 µL of methanol, 150 µL of chloroform, and 450 µL of deionized 
water were added to the sample in a microcentrifuge tube in sequence and vortexed after 
the addition of each solution. The sample was centrifuged for 5 minutes at 13 000 g and 
the upper aqueous phase was removed. About 450 µL of methanol was added to the 
interface layer containing protein and the mixture was vortexed. The sample was 
centrifuged again for 5 minutes at 13 000 g and a protein pellet was obtained. The pellet 
was left to air-dry for about one hour and resolubilized in 100 µL of HEPES buffer. The 
phosphorylated protein sample was quantified using the Bradford Assay. 
Samples were diluted in 2X SDS-PAGE buffer containing 20 mM dithiothreitol, 
6% SDS, 0.25 M Tris (pH 6.8), 10% glycerol, 10 mM NaF and bromophenyl blue (all 
Sigma). The samples were heated for 10 minutes at 95⁰ C for western blot analysis or 
frozen at -20º C for storage.  
2.4.2. - Western blot analysis 
Thirty micrograms of protein sample was loaded and separated using a Mini-
PROTEAN Precast Gels (BioRad). The gels were run in the BioRad Mini-PROTEAN 
Tetra Cell at 200 V for about 45 minutes in the 1X electrode buffer containing 0.30% 
Tris-base (Sigma), 0.14% glycine (MP Biomedicals, Inc) and 0.1% SDS. Correct loading 
and running of the protein gels was determined by staining with Brilliant Blue G 
Concentrate (Sigma) for 20 minutes. The gel was de-stained using 50% methanol 
(Sigma) and 10% acetic acid (Sigma) for 5 hours. The de-staining solution was changed 
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several times until the background was washed away and the protein bands were clearly 
visible. 
Protein was transferred from the gel to a polyvinylidene fluoride (PVDF) 
membrane (BioRad) using the BioRad Mini Trans-Blot Electrophoretic Transfer Cell. 
The transfer was carried out at 4⁰ C for 30 minutes at 100 V in the transfer buffer 
containing 1X electrode buffer, 10% methanol and 0.1% SDS. Transfer was confirmed 
by staining the membrane with 0.1% Ponceau S in 5% acetic acid (Sigma) for 15 minutes 
and washing the background with distilled water. After transfer was confirmed, the 
membrane was washed with the blotting buffer, containing 25 mM Tris (pH 7.4) 0.15 
NaCl and 0.1% Tween, until the stain was removed.  
2.4.3. - Detection of proteins 
Antibodies specific for ERK1/ERK2, phospho-ERK1/ERK2, JNK, phospho-JNK, 
and phospho- p38 MAPK were purchased from R&D Systems. Antibodies specific for 
p38 MAPK and β-actin were purchased from BioLegend. A secondary goat anti-rabbit 
IgG, horseradish peroxidase (HRP) - conjugated antibody was used for detection of the 
primary antibody (R&D Systems).  
ERK1(MAPK3)/ERK2(MAPK1) are rabbit polyclonal antibodies that bind to 44 
kDa peptides. To detect unphosphorylated ERK1/ERK2, the PVDF membrane containing 
transferred protein was incubated with 0.1 µg/mL rabbit anti-human ERK1/ERK2 
antibody in a blocking solution for one hour at room temperature with gentle agitation. 
To detect for phospho-ERK1 (T202/Y204)/ERK2(T185/Y187), the membrane was 
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incubated with 0.05 µg/ml rabbit anti-phospho-ERK1/ERK2 antibody in a blocking 
solution for one hour at room temperature with gentle agitation. 
JNK(SAPK1) is a rabbit polyclonal antibody that binds to 46 kDa and 54 kDa 
peptides. To detect unphosphorylated JNK, the PVDF membrane containing transferred 
protein was incubated with 0.2 µg/mL rabbit anti-human JNK antibody in a blocking 
solution for one hour at room temperature with gentle agitation. To detect for phospho-
JNK (T183/Y185), the membrane was incubated with 0.5 µg/mL rabbit anti-phospho-
JNK antibody in a blocking solution for one hour at room temperature. 
P38 MAPK is a rabbit polyclonal antibody that binds to 38 kDa peptides. To 
detect unphosphorylated p38 MAPK, the PVDF membrane containing transferred protein 
was incubated with 0.5 µl/mL rabbit anti-human JNK antibody in a blocking solution for 
one hour at room temperature with gentle agitation. To detect for phospho-p38 MAPK 
(T180/Y182), the membrane was incubated with 0.5 µg/mL rabbit anti-phospho-p38 
MAPK antibody in a blocking solution for one hour at room temperature. 
Beta-Actin is a rabbit polyclonal antibody that binds to 45 kDa peptides. To detect 
β-actin, the PVDF membrane containing transferred protein was incubated with 0.5 
µl/mL rabbit anti-human β-actin antibody in a blocking solution for one hour at room 
temperature with gentle agitation. 
After incubation with each of the primary antibodies, the membranes were 
washed at room temperature for one hour with 5 changes of blotting buffer containing 25 
mM Tris (pH 7.4), 0.5 M NaCl and 0.1% Tween. The membranes were incubated in with 
0.5 µg/ml anti-rabbit IgG-HRP secondary antibody for one hour at room temperature. 
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The membranes were washed again at room temperature for one hour with 5 changes of 
blotting buffer.  
Chemiluminescent peroxidase substrate working solution (Sigma) was prepared 
by mixing 1 part of the chemiluminescent reagent with 2 parts of the chemiluminescent 
reaction buffer. The working solution was poured over the membrane and left for 5 
minutes in the absence of light. The excess solution was drained, the membrane wrapped 
in a plastic wrap and placed in an autoradiography cassette. The membrane was exposed 
to autoradiography film (Kodak) for 30 seconds. After exposure, the film was developed 
using the Kodak X-OMAT 1000A Processor.      
2.5. - Detection of mRNA 
Since the expression of both RANK and RANKL have been observed in breast 
cancer cell lines and linked to mammary tumorigenesis (Gonzalez-Suarez et al., 2010). 
RT-PCR analysis was conducted using RNA isolated from MCF-7 breast cancer cells to 
examine the changes in RANK and RANKL gene expression with 0.1 µM endosulfan 
exposure.  
2.5.1. - Preparing cytoplasmic lysates and RNA purification 
For experimentation, one million cells were plated in four 25 cm
2 
flasks with 5 
mL of media and incubated at 37⁰ C in 5% CO2. One flask comprised of the control 
condition, while the remaining three flasks were stimulated with 0.1 µM endosulfan. 
Media was not removed or changed from the flasks until RNA was extracted.  RNA was 
extracted after 24 hours, 48 hours and 72 hours.  
37 
 
About 1 million cells were harvested and lysed with 600 µL of CytosALL reagent 
(Thermo Scientific) and mixed with 6 µL of RNase inhibitor (Applied Biosystems). The 
pellet was resuspended in water until completely dissolved and incubated for 5 minutes 
on ice. The cell lysate was centrifuged at 4º C for one minute at 15 000 g in a table top 
microcentrifuge. The supernatant cytoplasmic lysate was retained. 
In order to purify the RNA, RNeasy Mini Kit was purchased from Qiagen. About 
100 µL retained after RNA extraction was added to 350 µL Buffer RLT with 1% β- 
mercaptoethanol and homogenized. About 250 µL was added to the lysate. The sample 
was then applied to RNeasy spin column placed in a 2 mL collection tube. The lysate was 
centrifuged in a microcentrifuge for 15 seconds at 10000 g.  Ethanol was added to allow 
total RNA binding to the membrane. After centrifugation, 500 µL of Buffer RPE was 
added to wash the spin column membrane and centrifuged for 15 seconds at 10000 g. The 
membrane was washed again with 500 µL of Buffer RPE for 2 minutes at 10000 g. RNA 
was eluted using 50 µL of RNase free water (Fisher) by centrifuging for 1 minute at 
10000 g in 1.5 mL collection tube. RNA was quantified using the A260/A280 reading on a 
UV spectrophotometer. 
2.5.2 - RNA reverse-transcribed to cDNA 
RNA was reverse-transcribed to cDNA using Superscript II RT enzyme and Oligo 
(dT)12-18 primers (Invitrogen). One µg of isolated RNA was combined with 1 µl of Oligo 
(dT)12-18 primers and 10 mM dNTPs. The reaction was heated to 65⁰ C for 5 minutes in 
order for the primers to anneal to the template mRNA strand. The reaction was chilled on 
ice immediately and 5X First Strand Buffer and 0.1 M DTT was added. The cDNA 
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synthesis was carried out at 42⁰ C for one hour using 200U Superscript II reverse 
transcriptase (Invitrogen). The reverse transcriptase was inactivated by heating at 70⁰ C 
for ten minutes. The cDNA samples were stored at -20⁰ C.  
 
2.5.3 - Polymerase chain reaction 
GAPDH, RANK, RANKL transcripts were amplified from constructed cDNA 
using RT-PCR. PCR reactions were carried out using a GoTaq Hotstart Polymerase 
(Applied Biosystems). GoTaq was activated with an initial incubation of 95⁰ C for 2 
minutes. One microlitre of cDNA was used as template for each amplification reaction. 
Glyceraldehyde 3-phosphatase dehydrogenase(GAPDH3) is a housekeeping gene 
used as a genomic control for possible contamination of cDNA samples and a positive 
PCR control. The following primers were used for amplifications: 5‟-
ACCACAGTCCATGCCATCAC-3‟ (sense) and 5‟-TCCACCACCCTGTTGCTGTA-3‟ 
(antisense), to produce 555 bp from genomic DNA and 451 bp from cDNA. The reaction 
mixture included 2 mM dNTPs, 10 µM primers, 25 mM MgCl2 and 0.2 UTaq. Following 
the initial activation, the reaction was followed by thirty five cycles of denaturing at 94⁰ 
C for 45 seconds, primer annealing at 57⁰ C for 1 minute and extension at 72⁰ C for 45 
seconds. The reaction was completed with final annealing for one cycle at 72⁰ C for 10 
minutes.  




GCACTGGCTTAAACTGTCATTCTCC-3‟ (antisense), to produce 452 bp fragments. 
The reaction mixture comprised of 2 mM dNTPs, 10 µM primers, 25 mM MgCl2 and 0.2 
UTaq. The reaction was started with an initial incubation of 95⁰ C for 2 minutes, 
followed by thirty five cycles of denaturing at 94⁰ C for 45 seconds, primer annealing at 
57⁰ C for 1 minute and extension at 72⁰ C for 45 seconds. The reaction was completed 
with final annealing for one cycle at 72⁰ C for 10 minutes.  
RANKL primers used for amplification of 389bp fragments were as follows: 5‟-
ACTGGATCCGGATCAGGATG-3‟ (sense) and 5‟ –AGCTGCGAAGGGGCACATGA-
3‟ (anti-sense). HT-29 cells were used as a positive control for RANKL gene expression. 
The reaction mixture for amplification included 2 mM dNTPs, 10 µM primers, 25 mM 
MgCl2 and 0.2 UTaq. The reaction was started with an initial incubation of 95⁰C for 2 
minutes, followed by thirty five cycles of denaturing at 94⁰ C for 45 seconds, primer 
annealing at 57⁰ C for 1 minute and extension at 72⁰ C for 45 seconds. The reaction was 
completed with final annealing for one cycle at 72⁰ C for 10 minutes.  
2.5.4. - Electrophoresis of PCR products 
The size of each PCR product was determined by electrophoresis through a 2% 
electrophoresis grade agarose (Sigma) gel in 1X TAE buffer at 100V for approximately 
45 minutes. Gels were stained with 0.5 ng/mL ethidium bromide for fifteen minutes and 
visualized under UV using a FluorChem
TM 
SP (Alpha Innotech) geldock, and images 




2.6 - Inhibition Studies 
 SB203580, a specific inhibitor of p38-MAPK pathway (Barancik et al., 2001) was 
used to inhibit the phosphorylation of p38 MAPK protein. SB203580 powder (Sigma) 
was reconstituted in DMSO to a concentration of 50 mM. SB203580 was further diluted 
with 0.1 µM endosulfan in charcoal dextran stripped media to a concentration to 50 µM. 
Cells were stimulated with and without inhibitor for 30 minutes and 45 minutes. Protein 

















3 - Results 
In order to rule out the possible effects contributed by undefined hormones 
present in serum, cells were cultured in low quantities of charcoal-stripped serum 24 
hours prior to the treatment with endosulfan. Charcoal dextran stripping reduces the 
serum concentration of many hormones and certain growth factors, such as 
estradiol, cortisol, corticosterone, the B vitamins, T3, T4 and prostaglandins. The 
removal of these hormones was essential prior to the treatment with endosulfan because 
they may interfere with the signalling pathways activated by the endosulfan and lead to 
synergistic or subtract from estrogenic responses.   
 
3.1 - MCF-7 Cells Proliferation in the Presence of Endosulfan 
The mean number of viable cells from all four conditions (Control, DMSO 
Control, 0.1 µM endosulfan, and 1.0 µM endosulfan) for three consecutive days at 24 
hours intervals are presented in Figure 6. The experiment was repeated three times and a 
graph was generated. The viable cell count ranged from 300,000 to 2,445,094 in a 25cm
2
 
flasks with 5mL of media. The mean number of cells treated with 0.1 µM endosulfan was 
significantly more than the mean number of cells in the DMSO control condition (p = 
0.00157) after 24 hours, after 48 hours (p = 0.00864) and after 72 hours (p = 0.00052). 
The mean number of cells treated with 1.0 µM endosulfan was also significantly greater 
than the mean number of cells in the DMSO control condition after 24 hours (p = 
0.03307); 48 hours (p = 0.00679) and 72 hours (p = 0.00028). The mean number of 
MCF-7 cells treated with 1.0 µM did not significantly differ from the mean number of 
cells treated with 0.1 µM endosulfan after 24 hours or 48 hours. However, the mean 
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number of cells treated with the lower concentration of endosulfan (0.1 µM) was 
significantly higher than the higher concentration (1.0 µM endosulfan) after 72 hours.  
Overall, the results indicate that treatment of MCF-7 cells with either endosulfan 
concentration shows a statistically significant increase in proliferative activity over 
control as measured at 24 through 72 hours of incubation.  Interestingly, although no 
significant difference in total cell counts was measured between the two endosulfan 
concentrations after 24 hours and 48 hours, there was a significant increase in cell 
number for the lower endosulfan (0.1 µM) concentration over the higher (1.0 µM) 
endosulfan concentration (Figure 6) after 72 hours.  This paradoxical situation of the 
lower concentration having more stimulatory effect on the cells than the higher 
concentration has also been seen with other organochlorines and will be discussed further 































Figure 6: Endosulfan treatment significantly increases MCF-7 cell counts 
Cells stimulated for 24, 48 and 72 hours with either 0.1 µM endosulfan or 1.0 µM 
endosulfan show a significant increase in cell number (*) (p≤0.05; n = 3) over cells 
cultured in DMSO as a vehicle control. Additionally, proliferation is greater for cells 
treated at lower concentration (0.1 µM) endosulfan for 72 hours (ǂ) from the higher 1.0 













3.2 - Activation of Intracellular MAPKK Pathways with Endosulfan 
Exposure 
 
After examining the effects of endosulfan stimulation on MCF-7 breast cancer 
cells, in particular proliferative effects, intracellular changes at the molecular level were 
investigated using protein isolation and Western blot analysis to detect changes in 
phosphorylation (activation) status of key proteins in the MAP kinase signalling cascade. 
Since the lower concentration (0.1 µM) was found to have more stimulatory effect on the 
cells, this endosulfan concentration was used for protein analysis studies. The 
phosphorylation status of three MAPKK pathways (ERK1/2, JNK and p38MAPK) after 
stimulation with low endosulfan concentration (0.1 µM) was explored.  
Protein isolated from unstimulated MCF-7 cells showed little phosphorylation of 
ERK2 protein (42 kDa) (Figure 7A). There was a slight increase in detectable 
phosphorylated ERK1/2 after 30 minutes of endosulfan stimulation but a darker band of 
phosphorylated ERK1/2 was observed after 45 minutes of endosulfan exposure. Protein 
isolated from unstimulated cells displayed mostly unphosphorylated forms of ERK2 
protein (42 kDa) (Figure 7B). There was a slight decrease in detectability of the 
unphosphorylated form of ERK2 after 30 minutes of endosulfan exposure but a much 
lighter band of unphosphorylated ERK2 was observed after 45 minutes of endosulfan 
exposure which correlates with the change in its state to the phosphorylated form.  
Unstimulated MCF-7 cells expressed little phosphorylated JNK protein (46 kDa) 
(Figure 8A) but JNK protein was clearly detected in its unphosphorylated form (Figure 
8B). Although there were no large changes in phosphorylated JNK protein after 30 
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minutes, the band for phosphorylated JNK appeared much darker after 45 minutes of 
endosulfan exposure. There was a decrease in the intensity of the band for 
unphosphorylated JNK after 30 minutes and after 45 minutes of endosulfan exposure 
which relates to the change in form to the phosphorylated state.   
Unstimulated MCF-7 cells showed negligible expression of phosphorylated 
p38MAPK protein (38 kDa) (Figure 9A). However, the band for phosphorylated 
p38MAPK appeared darker after 30 minutes and after 45 minutes of endosulfan 
exposure. Consequently, protein isolated from unstimulated cells displayed only the 
unphosphorylated form of p38 MAPK protein (38kDa) (Figure 9B). The band for 
unphosphorylated p38 MAPK appeared lighter after 30 minutes and after 45 minutes of 
endosulfan exposure.   
Beta actin was used as a positive control as it is a ubiquitous protein found in 
eukaryotic cell cytoskeletons. Beta actin was present in unexposed and endosulfan 
exposed MCF-7 cells and the band for beta actin protein in unexposed cells appeared 
similar in intensity compared to the band for beta actin protein in endosulfan exposed 
cells. Hence, there appears to be no difference in the expression of this protein in these 















            
 
 
Figure 7: Western blot analysis of protein isolated from endosulfan exposed MCF-7 
breast cancer cells shows ERK1/2 phosphorylation.  
A - Western blot analysis of whole protein samples isolated from unexposed MCF-7 cells 
(UE) and endosulfan exposed MCF-7 cells for 30 minutes (E30) & 45 minutes (E45) and 
probed with antibodies specific for the phosphorylated form of ERK1/2 (44 kDa and 42 
kDa respectively) shows a slight increase in detectable phosphorylated ERK1/2 after 30 
minutes and a greater increase in phosphorylated ERK1/2 after 45 minutes. B - Western 
blot analysis of whole protein samples isolated from unexposed MCF-7 cells (UE) and 
exposed MCF-7 cells for 30 minutes (E30) & 45 minutes (E45) and probed with 
antibodies specific for ERK2 (42 kDa) shows a slight decrease in unphosphorylated 
ERK2 after 30 minutes and a greater decrease in unphosphorylated ERK2 after 45 
minutes.   
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Figure 8: Western blot analysis of protein isolated from endosulfan exposed MCF-7 
breast cancer cells shows JNK phosphorylation.  
A - Western blot analysis of whole protein samples isolated from unexposed MCF-7 cells 
(UE) and 0.1 µM endosulfan exposed MCF-7 cells for 30 minutes (E30) & 45 minutes 
(E45) and probed with antibodies specific for phospho-JNK (46 kDa) shows no increase 
in phosphorylated JNK after 30 minutes but a slight increase in phosphorylated JNK after 
45 minutes. B - Western blot analysis of whole protein samples isolated from 
unstimulated MCF-7 cells (UE) and endosulfan exposed MCF-7 cells for 30 minutes 
(E30) & 45 minutes (E45) and probed with antibodies specific for JNK (46 kDa) shows a 
slight decrease in unphosphorylated JNK after 30 minutes but a greater decrease in 
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Figure 9: Western blot analysis of protein isolated from endosulfan exposed MCF-7 
breast cancer cells shows p38 MAPK phosphorylation.  
A - Western blot analysis of whole protein samples isolated from unexposed MCF-7 cells 
(UE) and endosulfan exposed MCF-7 cells for 30 minutes (E30) & 45 minutes (E45) and 
probed with antibodies specific for phospho-p38MAPK (38 kDa) shows an increase in 
the intensity of the band for phosphorylated p38 MAPK after 30 minutes and after 45 
minutes. B - Western blot analysis of whole protein samples isolated from unexposed 
MCF-7 cells (UE) and exposed MCF-7 cells for 30 minutes (E30) & 45 minutes (E45) 
and probed with antibodies specific for p38MAPK (38 kDa) shows a slight decrease in 
unphosphorylated JNK after 30 minutes and after 45 minutes.   
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Figure 10: Western blot analysis of beta actin protein isolated from both unexposed 
and endosulfan exposed MCF-7 cells.  
Western blot analysis of whole protein samples isolated from unexposed MCF-7 cells (A) 
and endosulfan exposed MCF-7 cells (B) and probed with antibodies specific for beta-
actin (45 kDa) showed no difference between the two conditions in terms of the intensity 













3.3 - Modulation of Gene Expression of RANK and RANKL with 
Endosulfan Exposure 
 The presence of RANK (452 bp) and RANKL (389 bp) cDNA was detected in 
unstimulated MCF-7 cells (Figure 11A). HT-29 human intestinal epithelial cells were 
used as a positive control for RANKL gene expression as very little RANKL cDNA was 
expected to be detected in MCF-7 cells. GAPDH (451 bp) was used as a positive RT-
PCR control as it is a ubiquitously expressed housekeeping gene always present in MCF7 
cells. Water was used as negative PCR controls to detect any contamination of PCR 
reagents with cDNA. After MCF-7 cells were exposed to 0.1 µM endosulfan for 72 
hours, the expression of RANK was no longer detected (Figure 11B) but RANKL cDNA 
expression levels appeared much greater. GAPDH expression levels did not appear to 
change in endosulfan exposed cells.  
 Three replicates of RANK and RANKL gene expression analysis from 0.1 µM 
endosulfan exposed MCF-7 cells are shown in Figure 12. Replicates were performed on 
three separate treatments of MCF-7 cells stimulated for 24 hours (S24), 48 hours (S48) 
and 72 hours (S72). Once again, HT-29 human intestinal epithelial cells were used as a 
positive control for RANKL gene expression. Unexposed MCF-7 cells displayed RANK, 
RANKL and GAPDH expression. Endosulfan exposed MCF-7 cells showed an overall 
gradual decrease in RANK detectability with the dissipation in the intensity of band, 
increase in RANKL detection with an increase in the intensity of the band and no change 
in GAPDH with no change in the intensity of the band. The gradual increase in RANKL 
gene expression was more evident in one of the replicates of RT-PCR analysis of MCF-7 
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cells exposed to 0.1 µM endosulfan (Figure 13). There was a slight increase in RANKL 
expression after 48 hours of exposure but a greater increase in the intensity of the band 





























Figure 11: RT-PCR analysis of RANK and RANKL expression levels in unexposed 
and 0.1µM endosulfan exposed MCF-7 breast cancer cells. 
A – RT-PCR showing the expression of RANK (452 bp) and RANKL (389 bp) cDNA in 
unexposed MCF-7 cells. HT-29 human intestinal epithelial cells used as a positive 
control for detection of RANKL gene expression. GAPDH (451 bp) used as a positive 
RT-PCR control in MCF7 cells. Water blanks used as negative PCR controls. B - RT-
PCR analysis showing the absence of RANK expression in MCF-7 cells exposed to 
0.1µM endosulfan for 72 hours. RANKL and GAPDH expression is detected in exposed 
cells. HT-29 cells used as a positive control for RANKL gene expression. Water blanks 
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Figure 12:  RT-PCR replicates of RANK and RANKL gene expression analysis from 
0.1 µM endosulfan exposed MCF-7 cells. A)Unexposed cells (UE) MCF-7 cells show 
RANK (452 bp), RANKL (389 bp) and GAPDH (451 bp) expression. B) Endosulfan 
exposed MCF-7 cells for 24 hours (E24), 48 hours (E48) and 72 hours (E72) shows a 
decrease in detection of RANK cDNA, an increase in RANKL cDNA expression and no 
change in GAPDH cDNA detection. HT-29 human intestinal epithelial cells (H) used as a 
positive control for RANKL gene expression detection and water blanks used as negative 
controls (C) for RT-PCR reactions.  
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Figure 13: Increase in RANKL cDNA detection with 0.1 µM endosulfan exposure 
over the span of 72 hours.  
RT-PCR analysis of MCF-7 cells exposed to 0.1µM endosulfan show a slight increase in 
detectable RANKL transcripts after 48 hours (E48) but the intensity of the band increased 
after 72 hours (E72). HT-29 cells (H) used as a positive control for RANKL gene 
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3.4 - Endosulfan induced p38 MAPK Intracellular Signalling Inhibited 
by SB203580 
  
 SB203580, a specific inhibitor of p38-MAPK pathway (Barancik et al., 2001) was 
used to inhibit the phosphorylation of p38 MAPK protein. Protein isolated from 0.1µM 
endosulfan exposed MCF-7 cells that were also treated with SB203580 inhibitor showed 
a slight decrease in detectable phosphorylated p38 MAPK (38 kDa) after 30 minutes but 
there was a greater decrease in the intensity of the phosphorylated p38MAPK band after 
45 minutes compared to cells exposed to endosulfan alone (Figure 9A). Accordingly, 
protein isolated from 0.1 µM endosulfan exposed MCF-7 cells treated with SB203580 
inhibitor showed an increase in the intensity of the unphosphorylated p38 MAPK band 
after 30 minutes and after 45 minutes compared to only endosulfan exposed cells (Figure 
9B).  This indicates that inhibition of endosulfan induced phosphorylation of the p38 
















            
 
 
Figure 14: Inhibition of p38 MAPK phosphorylation induced by 0.1 µM endosulfan 
exposure with SB203580.  
A - Western blot analysis of whole protein samples isolated from endosulfan exposed 
MCF-7 cells for 30 minutes (E30) & 45 minutes (E45) and endosulfan exposed cells 
treated with SB203580 inhibitor for 30 minutes (I+E30) & 45 minutes (I+E45). The 
membrane was probed with antibodies specific for phospho-p38MAPK (38 kDa) and 
shows a decrease in phosphorylated p38 MAPK after 30 minutes and after 45 minutes of 
inhibitor treatment. B - Analysis of whole protein samples isolated from endosulfan 
exposed MCF-7 cells for 30 minutes (E30) & 45 minutes (E45) and endosulfan exposed 
cells treated with SB203580 inhibitor for 30 minutes (I+E30) & 45 minutes (I+E45). The 
membrane was probed with antibodies specific for p38MAPK (38 kDa) and shows a 
increase in unphosphorylated p38 MAPK after 30 minutes and after 45 minutes of 
inhibitor treatment.  
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4. - Discussion 
4.1. Endosulfan Remains to be a Global Health Concern 
Endosulfan is used as an insecticide all over the world. It is a ubiquitous 
contaminant in the environment and resistant to degradation processes. Many studies 
have shown that exposure to endosulfan is positively correlated with endocrine disruption 
(Lemaire et al., 2006), reproductive and immune dysfunctions (Saiyed et al., 2003), and 
cancers such as those of the breast (Ibarluzea et al., 2004; Hansen and Matsumura, 2001). 
Despite the discontinuation of the use of endosulfan since January 2011 in Canada 
(Health Canada), it is expected to persist in the environment because the half-life of an 
endosulfan metabolite, endosulfan sulphate, is on the order of weeks to years (Leonard et 
al., 2001; Wan et al., 2005b). Hung et al. (2005) proposed that the atmospheric half-life 
for endosulfan (α) is 38 years in the Canadian Arctic. Endosulfan and its metabolites have 
regularly been detected in groundwater, surface water, sediment and rain and snow in 
many regions of the world (Kumari et al., 2007; Tuduri et al., 2006; Herbert et al., 2004; 
Schulz, 2004; Tariq et al., 2004). Due to its continued use in some developing countries 
(Jia et al., 2008) and widespread atmospheric transport and deposition, it still remains an 
important global public health concern. 
 
Endosulfan is also a highly toxic substance. Low concentrations of endosulfan 
exert significant reproductive and endocrine-disruptive effects. In particular, endosulfan 
evokes estrogenic responses on human MCF-7 breast cancer cells (Li et al., 2006; Soto et 
al., 1995). Physiological concentrations of endosulfan (α) and (β) in humans range from 
17.72 ng/g lipid found in female adipose tissue (Cerrillo et al., 2005) to 2.44ng/mL found 
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in cord serum (Mariscal-Arcas et al., 2010). Therefore, comparable concentrations of 0.1 
µM and 1 µM endosulfan were used in order to optimize the relevance of our study.  
 
4.2. - Endosulfan Stimulates Proliferation in MCF-7 cells 
Previous research has shown that exposure to endosulfan causes proliferation of 
MCF-7 human breast cancer cells at concentrations of 10-25 µM (Li et al., 2006; Soto et 
al., 1995). Our research confirms the proliferative effects of much lower concentrations 
of endosulfan on these same MCF-7 cell type (Figure 6). Endosulfan was found to be 
stimulatory at both 0.1 µM and 1.0 µM concentrations at 24 hours, 48 hours and 72 
hours. However, there was no significant difference in terms of cell proliferation between 
these two concentrations at 24 hours and 48 hours. This can be attributed to the notion 
that both of these concentrations are relatively low and cause similar stimulatory effects 
at 24 hours and 48 hours. However, exposure to the lower concentration (0.1 µM) of 
endosulfan caused greater proliferation than the higher concentration (1.0 µM 
endosulfan) after 72 hours. Exposure to higher concentrations for a prolonged period of 
time may be toxic and cause cell death. The dose-response pattern is not yet fully 
understood; however, endosulfan sulphate, the breakdown product of endosulfan, is 
considered to be as toxic as the parent isomers (Leonard et al., 2001). Therefore, this 
greater accumulation of endosulfan metabolites at 72 hours in the cells exposed to higher 
concentrations may be toxic to the cells. Conversely, the lower concentrations may be 
more involved in activating estrogen receptor (ER) α and inducing smaller Ca
2+
 influx 
(Watson et al., 2007). Smaller accumulation of Ca
2+
 over a prolonged period may lead to 
59 
 
more proliferative responses in the long term. The notion that a lower concentration had a 
greater stimulatory effect than the higher concentration may also forecast the possibility 
that the lower concentration had a more subtle effect on activating gene expression. 
Exposure to low concentrations of endosulfan has been shown to increase the relative 
amount of the 16 alpha-hydroxyestrone metabolite which is involved in enhancing breast 
cell growth in comparison to 2-hydroxyestrone which inhibits breast cell proliferation 
(Bradlow et al., 1995).  
 The observation that very low concentrations of endosulfan can cause cancer cell 
stimulation is important because these concentrations of organochlorines and other 
estrogen mimicking compounds present in our environment may be an important 
etiological factor in the development and progression of breast cancer. This suggests that 
these low concentrations of endosulfan that were otherwise known to be subtoxic can 
have deleterious impact on human health. 
4.3. - Endosulfan Activates Proteins of MAPKK Signaling Pathway 
Activation of MAPKK signalling cascades can lead to opposing cellular responses 
such as proliferation, growth arrest, cell differentiation and apoptosis simultaneously 
depending on the duration and strength of the external stimulation and on the cell type 
(Shaul and Seger, 2007). 
In MCF-7 breast cancer cell lines, low concentrations of endosulfan appear to be a 
potent activator of some non-genomic signalling pathways that can be connected to cell 
proliferation events. The non-genomic pathways activated by estrogen mimicking 
compounds independent of estrogen receptor activation are not yet fully elucidated 
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(Hatakeyama et al., 2002).  Nevertheless, organochlorine pesticides cause the activation 
of MAPKK signalling cascades that play a critical role in cell survival, proliferation and 
differentiation, ultimately altering cell behaviour (Ledirac et al., 2005). The MAPKK 
cascades are found in all eukaryotic cells including human MCF-7 breast cancer cells. 
Our research shows that endosulfan causes activation of key proteins within the MAPKK 
signalling pathway including ERK1/2, JNK and p38 MAPK. Activation of MAPKK 
signalling cascades by organochlorine pesticides in breast cancer cells is a novel 
phenomenon which has not been explored in the past.  
The presence of some detectable levels of phosphorylated ERK2 protein in non 
treated MCF-7 cells illustrates that these breast cancer cells already have slightly 
activated ERK2 signalling which is known to be involved in promoting cell-cycle 
progression by inactivating a cell-cycle inhibitory kinase (Palmer et al., 1998) and 
stimulating cell proliferation by indirectly inducing cyclin D1 (Treinies et al., 1999). 
After exposure to low concentrations (0.1 µM) of endosulfan, there was a marked 
increase in phosphorylated ERK1/2 proteins especially after longer exposure of 45 
minutes (Figure 7). This signifies that endosulfan is a potent activator of ERK1/2 
signaling pathway, further augmenting cell proliferation and possibly inactivating cell 
cycle inhibitory kinases. Our results are consistent with previous studies that reported 
activation of ERK1/2 by 50 µM heptachlor in human lymphocytes (Chuang and Chuang, 
1998) and by both endosulfan and heptachlor in human keratinocyte (HaCaT) cells 
(Ledirac et al., 2005).  
Similarly, although some phosphorylated JNK protein was present, most of the 
JNK protein was detected in unphosphorylated form in non treated MCF-7 cells. The 
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activation of this pathway is linked with the induction of cell differentiation and 
apoptosis (Xia et al., 1995). After exposure to endosulfan, there was a marked increase in 
phosphorylated JNK proteins especially after a longer exposure of 45 minutes (Figure 8). 
These findings correlate with a previous study illustrating the activation of JNK signaling 
pathway by endosulfan and heptachlor in human keratinocyte cells (Ledirac et al., 2005). 
Therefore, it appears that organochlorines, in particular endosulfan, is capable of 
activating JNK signaling pathway and consequently regulating gene expressions involved 
in cell differentiation and apoptosis.    
Similar to the JNK pathway, the p38 MAPK protein is also involved in the cell 
differentiation and apoptosis. Contrary to the JNK protein discussed earlier, p38 MAPK 
signaling protein was found in an inactive state in untreated MCF7 cells. A striking 
phosphorylation of p38 MAPK protein occurred after 30 minutes exposure with low 
concentration of endosulfan illustrating that endosulfan is a potent activator of p38 
MAPK signalling pathway (Figure 9).  Supporting evidence from previous research also 
demonstrated the presence of non-activated form of p38 MAPK found in some tumours 
such as in breast cancer which could be stimulated with glypican-3, a proteoglycan 
involved in cell proliferation and survival (Buchanan et al., 2010). The transformation of 
non-activated form of p38 MAPK to the activated form by endosulfan in cancer cells 
depicts the importance of this pathway is mediating the mammary epithelium 
proliferation and differentiation in tumours.  
Hence this shows the complex interplay of MAPKK signalling proteins activated 
by low concentrations of endosulfan which would in part explain the observed increase in 
cell proliferation (Figure 6).  Activation of intracellular pathways by this ubiquitous toxin 
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is an important finding because it suggests the role of MAPKK pathway in regulating 
organochlorine- induced gene alternations and alterning cell behaviour. It raises attention 
on better understanding of the underlying mechanisms of this pathway suspected to be 
involved in mammary epithelium proliferation and tumorigenesis.   
When the p38 MAPK pathway in endosulfan treated MCF-7 cells was inhibited 
with a specific inhibitor, SB203580, a marked decrease in phosphorylated p38 MAPK 
protein and a remarkable increase in unphosphorylated p38 MAPK protein was detected 
(Figure 14). This confirmed that the phosphorylation of p38 MAPK protein was caused 
by endosulfan exposure. Importantly, blocking endosulfan-induced phosphorylation of 
the p38 protein can be achieved with this select inhibitor in order to further investigate 
downstream mechanisms and effects of endosulfan exposure on gene expression.  Since 
activation of p38 can be completely blocked in endosulfan exposed cells, future research 
could look into whether endosulfan induced RANK and RANKL gene expression is 
regulated through the p38 MAPK pathway. This will add to the understanding of the 
regulation of RANK and RANKL signalling axis and provide a relationship between the 
MAPKK pathway and RANK/RANKL expression in human breast cancer.  
4.4. - Endosulfan Modulates RANK and RANKL Gene Expression 
 RANK is constitutively expressed throughout development in normal mammary 
epithelial cells (Srivastava et al., 2003). Although previous research stated that RANKL 
is only found in female mammary epithelial cells during pregnancy and lactation (Theill 
et al., 2002; Kotake et al., 2001; Kong et al., 1999), more recent evidence illustrates it is 
also weakly expressed in tissues isolated from human breast tumours (Reinholz et al., 
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2002) and in metastatic cells (Bhatia et al., 2005). Our research supports this finding 
since RANKL is weakly expressed in MCF-7 cells (Figure 11).  
Previous research showed that the induction of RANKL is essential for the 
formation of lobulo-alveolar mammary structures during pregnancy (Fata et al., 2000). 
This induction is mediated by reproductive hormones such as progesterone and prolactin 
(Schramek et al., 2010; Henninghausen and Robinson, 2001). A recent study showed that 
synthetic progesterones (progestins) such as MPA triggers a massive induction of 
RANKL in mammary gland (Schramek et al., 2010; Gonzalez-Suarez et al., 2010). 
Similarly, hormone mimicking endosulfan also caused upregulation of RANKL gene 
expression in MCF-7 cells (Figure 11).  Additionally, exposure to a low concentration of 
endosulfan for 72 hours caused RANK expression to disappear in MCF-7 cells (Figure 
11).   Importantly, endosulfan stimulation of MCF-7 cells caused an overall gradual 
decrease in RANK and increase in RANKL over the course of a three day period.  This 
indicates that endosulfan exposure causes specific changes in gene expression. 
Organochlorines have been shown to induce MAPK signaling pathway, in particular the 
p38 kinase cascade, stimulating activator protein (AP-1) gene expression in human 
endometrial Ishikawa cells (Frigo et al., 2004).  
Similar to RANK and RANKL, AP-1 is involved in controlling a number of 
cellular processes including differentiation, proliferation, and apoptosis (Ameyer et al., 
2003). This provides insight into the relevance and perhaps detrimental effects of 
exogenous compounds on altering gene expression and fate of the cell.  It is known that 
hormones and hormone derivatives play a prominent role in the activation of 
RANK/RANKL signalling axis that drives the mammalian cells into the cell cycle 
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progression and differentiation (Schramek et al., 2010; Gonzalez-Suarez et al., 2010). 
Induction of RANKL after stimulation with progesterone or prolactin increases 
proliferation in mammary epithelium during mammary gland lactational morphogenesis 
(Beleut et al., 2010; Fata et al., 2000).  
However, induction of RANK/RANKL signalling axis in the absence of 
hormones can also induce hyper proliferation of mammary epithelial cells (Fernandez-
Valdivia et al., 2010; Gonzalez-Suarez et al., 2010) linking this pathway to mammary 
tumorigenesis. Currently, Stat5a activation is the mechanism through which 
RANK/RANKL gene expression is thought to be regulated. No current data exists on 
how other signalling pathways may contribute to the regulation of RANK and RANKL 
gene expression in breast cells. Since our results show that endosulfan alters RANK and 
RANKL gene expression in human MCF-7 breast cancer cells and is also a potent 
activator of key proteins in the MAPKK signalling pathway, a study on how MAPKK 
pathways in breast cancer cells may regulate RANK/RANKL gene expression will 
contribute new knowledge in this field. 
Therefore, the results of this study contribute to further understanding of the 
detrimental impact of endosulfan as an environmental toxin to humans, provide further 
important measurable connections between environmental toxins and breast cancer, 
elucidate the mechanisms of action of cell behavior changes with endosulfan exposure 
and provide new knowledge of RANK/RANKL regulation by intracellular pathways.   
Low but significant concentrations of endosulfan and other estrogen mimicking 
compounds present in our environment can have adverse impact on humans. A direct 
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correlation between the level of exposure to organochlorines and the risk of breast cancer 
is not yet determined but it seems to be an important etiological factor in the development 
and progression of breast cancer. A better understanding of the underlying mechanisms 
causing cell proliferation after endosulfan exposure and also the mechanisms involved in 
mammary epithelium proliferation and tumorigenesis is required. Furthermore, the 
possibility of the regulation of RANK and RANKL genes through the activation of 
intracellular kinase pathways uncovers a new area of research of immense clinical 
relevance.  
4.5 - Advantages and Disadvantages of MCF-7 Breast Cancer Cell Lines 
Used in this Study 
 Using an in vitro model to study the effects of endosulfan on MCF-7 breast cancer 
cells presented a number of advantages and disadvantages. MCF-7 breast cancer cell 
lines were easy to handle and easy to replace when contaminated due to their ability to 
grow and self-replicate in infinite quantities. However, one of the disadvantages of using 
these cell lines is that MCF-7 cells may display genotypic and phenotypic drift after 
continual culturing. Although, most MCF-7 cells appear morphologically identical, 
subpopulations and continual culturing may develop variations in cell growth rate, 
hormone receptors and karyotypes (Bahia et al., 2002). Also, MCF-7 cell lines used in 
this study were derived from pleural effusions and not from the primary breast tumours. 
Therefore, these cells might have already possessed characteristics of later-stage 
metastatic tumours as opposed to the primary tumours in the breast. Therefore in order to 
determine a direct correlation between the level of exposure to organochlorines and the 
risk of breast cancer, the use of primary cell cultures will also be valuable.  
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4.6 - Conclusions and Future Directions 
 Concentrations of endosulfan used in this study were similar to physiological 
levels found in humans. As previously mentioned, endosulfan is persistent in the 
environment and its main metabolite, endosulfan sulphate, is bioaccumulative. 
Endosulfan exhibits estrogenic properties, which may relate to an increase in the risk of 
breast cancer or may impact the progression of the disease. Our results found endosulfan 
to be more stimulatory at lower concentrations and toxic at higher concentrations. In fact, 
a study by Bulayeva & Watson (2004) described that the estrogenic effect of endosulfan 
showed a bimodal response whereby the estrogenic responses were observed at very low 
or high levels, but not at medium levels. It would be interesting to measure endosulfan 
levels present in women with breast cancer and whether the amount of endosulfan present 
is correlated with the etiology and progression of breast cancer.   
 
 In addition, our study tested the effects of endosulfan in the absence of 
endogenous hormones. It would be intriguing to look at whether the presence of 
endogenous hormones and growth factors have a synergistic or antagonistic effect on 
breast epithelial cell proliferation and tumorigenesis. Endosulfan causes activation of key 
proteins within the MAPKK signaling pathway including ERK1/2, JNK and p38 MAPK 
that can be connected to mammary epithelium proliferation and tumorigenesis. Further 
studies may explore other pathways important to cell survival and differentiation. 
Additionally, how these pathways impact the phosphorylation status of Stat5a will need 




Our study focused on the induction or dissipation of RANK and RANKL gene 
expression based on semi-quantitative methods using PCR and densitometry. The effects 
of low concentrations of endosulfan could be further investigated using quantitative real 
time PCR to measure changes in transcript levels and to compare the statistical 
differences. Our results showed that endosulfan caused an upregulation of RANKL gene 
expression while simultaneously causing down regulation of RANK gene expression. 
Induction of RANKL is correlated with mammary epithelial proliferation, however, there 
is no current data available on this relationship between RANK expression decrease with 
the induction of RANKL expression. It would be noteworthy to study the underlying 
mechanisms of intracellular pathways having opposing effects on RANK and RANKL 
expression in breast cell lines.  This may be of interest in the study of breast cancer 
progression and metastasis as breast tumours show varying amounts of expression of 
RANK (Gonselez-Suarez, 2010).  
Therefore this research provides important new insight into the regulation of 
genes known to be important in breast biology and breast cancer through important 








5. – Literature Cited 
 
Abalis, I. M., Eldefrawi, M. E., and Eldefrawi, A. T. (1986). Effects of insecticides on 
GABA-induced chloride influx into rat brain microsacs. Journal of Toxicology 
and Environmental Health, 18:13-23. 
 
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, 
A., Perez, L., Klein, R., and Nebreda, A. R. (2000). Essential role of p38alpha 
MAP kinase in placental but not embryonic cardiovascular development. 
Molecular Cell, 6(1): 109-116. 
 
Ameyar, M., Wisniewska, M., and Weitzman, J. B. (2003). A role for AP-1 in apoptosis: 
the case for and against. Biochimie, 85(8): 747-752. 
 
Andersen, H. R., Vinggaard, A. M., Rasmussen, T. H., Gjermandsen, I. M., and 
Bonefeld-Jorgensen, E. C. (2002). Effects of currently used pesticides in assays 
for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicology and 
Applied Pharmacology, 179(1): 1-12. 
 
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., 
Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., and Galibert, L. (1997). A 
homologue of the TNF receptor and its ligand enhance T-cell growth and 
dendritic-cell function. Nature, 390: 175-179. 
 
Apter, D., Reinilä, M., and Vihko, R. (1989). Some endocrine characteristics of early 
menarche, a risk factor for breast cancer, are preserved into adulthood. 
International Journal of Cancer, 44(5): 783-787.  
 
Arrebola, F. J., Martinez Vidal, J. L., and Fernandez-Gutierrez, A. (2001). Analysis of 
endosulfan and its metabolites in human serum using gas chromatography-tandem 
mass spectrometry. The Journal of Chromatographic Science, 39(5): 177-182. 
 
Bachmann, M. F., Wong, B. R., Josien, R., Steinman, R. M., Oxenius, A., and Choi, Y. 
(1999). TRANCE, a tumor necrosis factor family member critical for CD40 
ligand-independent T helper cell activation. Journal of Experimental Medicine, 
189: 1025-1031. 
 
Bahia, H., Ashman, J, E., Cawkwell, L., Lind, M., Monson, J, T., Drew, P. J., and 
Greenman, J. (2002).  Karyotypic variation between independently cultured 
strains of the cell line MCF-7 identified by multicolour fluorescence in situ 
hybridization. International Journal of Oncology, 20: 489-494 
 
Barancík, M., Bohácová, V., Kvackajová, J., Hudecová, S., Krizanová, O., and Breier A. 
(2001). SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal 
agent of P-glycoprotein-mediated multidrug resistance. European Journal of 




Beleut, M., Rajaram, R. D., Caikovski, M., Ayyanan, A., Germano, D., Choi, Y., 
Schneider, P., and Brisken, C. (2010). Two distinct mechanisms underlie 
progesterone-induced proliferation in the mammary gland. Proceedings of the 
Natural Academy of Sciences of the United States of America, 107(7): 2989-2994 
 
Beleut, M., Rajaram, R. D., Caikovski, M., Ayyanan, A., Germano, D., Choi, Y., 
Schneider, P., and Brisken, C. (2010). Two distinct mechanisms underlie 
progesterone-induced proliferation in the mammary gland. Proceedings of the 
Natural Academy of Sciences of the United States of America, 107(7): 2989-2994. 
 
Beral, V., and Million Women Study Collaborators. (2003). Breast cancer and hormone-
replacement therapy in the Million Women Study. Lancet, 362(9382): 419-427. 
 
Bernstein L. (2002). Epidemiology of endocrine-related risk factors for breast cancer. 
Journal of Mammary Gland Biology and Neoplasia, 7(1): 3-15 
Bhatia, P., Sanders, M. M., and Hansen, M. F. (2005). Expression of receptor activator of 
nuclear factor-kappaB is inversely correlated with metastatic phenotype in breast 
carcinoma. Clinical Cancer Research, 11(1):162-165  
 
Biggs, M. L., Davis, M. D., Eaton, D. L., Weiss, N. S., Barr, D. B., Doody, D. R., Fish, 
S., Needham, L. L., Chen, C., and Schwartz, S. M. (2008). Serum organochlorine 
pesticide residues and risk of testicular germ cell carcinoma: a population-based 
case-control study. Cancer Epidemiology, Biomarkers and Prevention, 17(8): 
2012-2018. 
 
Bonefeld-Jorgensen, E. C., Grunfeld, H. T., and Gjermandsen, I. M. (2005). Effect of 
pesticides on estrogen receptor transactivation in vitro: a comparison of stable 
transfected MVLN and transient transfected MCF-7 cells. Molecular and Cellular 
Endocrinology, 244(1-2): 20-30. 
 
Bonefeld-Jorgensen, E. C., Grünfeld, H. T., and Gjermandsen, I. M. Effect of pesticides 
on estrogen receptor transactivation in vitro: a comparison of stable transfected 
MVLN and transient transfected MCF-7 cells. Molecular and Cellular 
Endocrinology, 244(1-2): 20-30. 
 
Bradlow, H. L., Davis, D. L., Lin, G., Sepkovic, D., and Tiwari, R. (1995). Effects of 
pesticides Environmental Health Perspectives, 103(7): 147-150. 
 
Buchanan, C., Stigliano, I., Garay-Malpartida, H. M., Rodrigues, G. L., Puricelli, L., 
Sogayar, M. C., Bal de Kier Joffé, E., and Peters, M. G. (2010). Glypican-3 
reexpression regulates apoptosis in murine adenocarcinoma mammary cells 
modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer 




Bulayeva, N. N., and Watson, C. S. (2004). Xenoestrogen-induced ERK-1 and ERK-2 
activation via multiple membrane-initiated signalling pathways. Environmental 
Health Perspectives, 112(15): 1481-1487. 
 
Burgess, T. L., Qian, Y., Kaufman, S., Ring, B. D., Van, G., Capparelli, C., Kelley, M., 
Hsu, H., Boyle, W. J., Dunstan, C. R., Hu, S., and Lacey, D. L. (1999). The ligand 
for osteoprotegerin (OPGL) directly activates mature osteoclasts. The Journal of 
Cell Biology, 145(3): 527-538. 
 
Cabaleiro, T., Caride, A., Romero, A., and Lafuente, A. (2008). Effects of in utero and 
lactational exposure to endosulfan in prefrontal cortex of male rats. Toxicology 
Letters, 176:58–67. 
 
Calle, E. E., Frumkin, H., Henley, S. J., Savitz, D. A., and Thun, M. J. (2002). 
Organochlorines and breast cancer risk. A Cancer Journal for Clinician, 52: 301-
309. 
 
Campoy, C., Jimenz, M., Olea-Serrano, M. F., Moreno-Frias, M., Canabate, F., Olea, N., 
Bayes, R., and Molina-Font, J. A. (2001). Analysis of organochlorine pesticides in 
human milk: preliminary results. Early Human Development, 65(2): 183-190. 
 
Canon, J., R., Roudier, M., Bryant, R., Morony, S., Stolina, M., Kostenuik, P. J., and 
Dougall, W. C. (2008). Inhibition of RANKL blocks skeletal tumor progression 
and improves survival in a mouse model of breast cancer bone metastasis. 
Clinical and Experimental Metastasis, 25:119–129. 
 
Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., and 
Karin, M. (2001).  IKK alpha provides an essential link between RANK signaling 
and cyclin D1 expression during mammary gland development. Cell, 107(6): 763-
775. 
 
Cerrillo, I., Granada, A., Lopez-Espinosa, M. J., Olmos, B., Jimenez, M., Cano, A., Olea, 
N., Fatima, Olea., and Serrano, M. (2005). Endosulfan and its metabolites in 
fertile women, placenta, cord blood, and human milk. Environmental Research, 
98(2): 233-239. 
 
Cerrillo, I., Olea-Serrano, M. F., Ibarluzea, J., Exposito, J., Torne, P., Laguna, J., 
Pedraza, V., and Olea, N. (2006). Environmental and lifestyle factors for 
organochlorine exposure among women living in Southern Spain. Chemosphere, 
62(11): 1917-1924. 
 
Chambers, A. F., Naumov, G. N., Vantyghem, S. A., and Tuck, A. B. Molecular biology 
of breast cancer metastasis. (2000). Clinical implications of experimental studies 




Chan, C. H., Bruce, G., and Harrison, B. (1994). Wet deposition of organochlorine 
pesticides and polychlorinated biphenyls to the Great Lakes. Journal of Great 
Lakes Research, 20: 546-560. 
 
Chang, L., and Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature, 
410: 37–40. 
 
Chatterjee, S., Kumar, V., Majumder, C. B., and Roy, P. (2008). Screening of some anti-
progestin endocrine disruptors using a recombinant yeast-based in vitro bioassay. 
Toxicology in Vitro, 22(3): 788-798. 
 
Chuang, L. F., and Chuang, R. Y. (1998). Heptachlor and the mitogen-activated protein 
kinase module in human lymphocytes. Toxicology, 128: 17–23. 
 
Coats, J. R. (1990). Mechanisms of toxic action and structure-activity 
relationships for organochlorine and synthetic pyrethroid insecticides. 
Environmental Health Perspectives, 87: 255-262. 
 
Cossette, L. J., Gaumond, I., and Martinoli, M. G. (2002). Combined effect of 
xenoestrogens and growth factors in two estrogen-responsive cell lines. 
Endocrine, 18(3): 303-308. 
 
Dalsenter, P. R., Dallegrave, E., Mello, J. R., Langeloh, A., Oliveira, T. R., and Faqi, A. 
S. (1999). Reproductive effects of endosulfan on male offspring of rats exposed 
during pregnancy and lactation. Human and Experimental Toxicology, 18(9): 583-
589. 
 
Dolcet, X., Llobet, D., Pallares, J., and Matias-Guiu, X. (2005). NF-kB in development 
and progression of human cancer.Virchows Archive, 446(5): 475-482. 
 
Dong, C., Yang, D. D., Wysk, M., Whitmarsh, A. J., Davis, R. J., and Flavell, R. A. 
(1998). Defective T cell differentiation in the absence of Jnk1. Science, 282: 
2092-2095. 
 
Dubois, M., Pfohl-Leszkowicz, A., De Waziers, I., Kremers, P. (1996). Selective 
induction of the CYP3A family by endosulfan and DNA-adduct formation in 
different hepatic and hepatoma cells. Environmental Toxicology and 
Pharmacology, 1(1): 249-256. 
 
Dutta, H., and Arends, D. A. (2003). Effects of endosulfan on brain acetylcholinesterase 
activity in juvenile bluegill sunfish. Environmental Research, 91:157–162. 
 
Ellis, G. K., Bone, H. G., Chlebowski, R., Paul, D., Spadafora, S., Smith, J., Fan, M., and 
Jun, S. (2008). Randomized trial of denosumab in patients receiving adjuvant 
aromatase inhibitors for nonmetastatic breast cancer. Journal of Clinical 




English, J., Pearson, G., Wilsbacher, J., Swantek, J., Karandikar, M., Xu, S., and Cobb, 
M. H. New insights into the control of MAP kinase pathways. Experimental Cell 
Research, 253(1): 255-270.  
 
Fata, J. E., Kong, Y. Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., 
Scully, S., Voura, E. B., Lacey, D. L., Boyle, W. J., Khokha, R., Penninger, J. M. 
(2000). The osteoclast differentiation factor osteoprotegerin-ligand is essential for 
mammary gland development. Cell, 103(1): 41-50. 
 
Fernandez-Valdivia, R., Jeong, J., Mukherjee, A., Soyal, S. M., Li, J., Ying, Y., Demayo, 
F. J., and Lydon, J. P. (2010). A mouse model to dissect progesterone signaling in 
the female reproductive tract and mammary gland. Genesis, 48(2):106-113. 
 
Ferrando, M. D., Andreu-Moliner, E., and Fernandez-Casalderrey, A. (1992). Relative 
senisitivity of Daphnia magna and Brachionus calyciflorus to five pesticides. 
Journal of Environmental Science and Health, 27: 511-522. 
 
Fransson-Steen, R., Flodstrom, S., and Warngard, L. (1992). The insecticide endosulfan 
and its two stereoisomers promote the growth of altered hepatic foci in rats. 
Carcinogenesis, 13(12): 2299-2303. 
 
Frigo, D. E., Tang, Y., Beckman, B. S., Scandurro, A. B., Alam, J., Burow, M. E., and  
McLachlan, J. A. (2004). Mechanism of AP-1-mediated gene expression by select 
organochlorines through the p38 MAPK pathway. Carcinogenesis, 25(2): 249-
261. 
 
Fuller, K., Wong, B., Fox, S., Choi, Y., and Chambers, T. J. (1998). TRANCE is 
necessary and sufficient for osteoblast-mediated activation of bone resorption in 
osteoclasts. Journal of Experimental Medicine, 188(5): 997-1001. 
 
Gerstenfeld, L. C., Sacks, D. J., Pelis, M., Mason, Z. D., Graves, D. T., Barrero, M., 
Ominsky, M. S., Kostenuik, P. J., Morgan, E. F., and Einhorn, T. A. (2009). 
Comparison of effects of the bisphosphonate alendronate versus the RANKL 
inhibitor denosumab on murine fracture healing. Journal of Bone and Mineral 
Research, 24(2):196-208. 
 
Gonzalez-Suarez, E., Jacob, A. P., Jones, J., Miller, R., Roudier-Meyer, M. P., Erwert, 
R., Pinkas, J., Branstetter, D., and Dougall, W. C. (2010). RANK ligand mediates 
progestin-induced mammary epithelial proliferation and carcinogenesis. Nature, 
468(7320):103-107  
 
Gormley, K. L., and Teather, K. L. (2003). Developmental, behavioral, and reproductive 
effects experienced by Japanese medaka (Oryzias latipes) in response to short-





Graves, L. M., Guy, H. I., Kozlowski, P., Huang, M., Lazarowski, E., Pope, R. M., 
Collins, M. A., Dahlstrand, E. N., Earp, H. S. 3rd, and Evans, D. R. (2000). 
Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature, 403: 328-
332. 
 
Grunfeld, H. T., and Bonefeld-Jorgensen, E. C. (2004). Effect of in vitro estrogenic 
pesticides on human oestrogen receptor alpha and beta mRNA levels. Toxicology 
Letters, 151(3): 467-80. 
 
Gutkind, S. J. (2002). Regulation of mitogen-activated protein kinase signalling networks 
by G-protein coupled receptors [online] 
(http://www.stke.org/cgi/content/full/OC_sigtrans;2000/40/re1) 
 
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., and Baldwin, A. S. Jr. 
(1999). NF-kappaB controls cell growth and differentiation through 
transcriptional regulation of cyclin D1. Molecular and Cellular Biology, 19(8): 
5785-5799. 
 
Haider, S. and Inbaraj, R. M. (1988). In vitro effect of malathion and endosulfan on the 
LH-induced oocyte maturation in the common carp, Cyprinus carpio (L.). Water 
Air & Soil Pollution, 39: 27-31. 
 
Hansen, M. E., and Matsumura, F. (2001). Effects of heptachlor epoxide on components 
of various signal transduction pathways important in tumor promotion in mouse 
hepatoma cells. Determination of the most sensitive tumor promoter related effect 
induced by heptachlor epoxide. Toxicology, 160:139-153. 
 
Harford, A. J., O‟Halloran, K., and Wright, P. F. A. (2005). The effects of in vitro 
pesticide exposures on the phagocytic function of four native Australian 
freshwater fish. Aquatic Toxicology, 75(4): 330-342. 
 
Harmes, D. C., and DiRenzo, J. (2009). Cellular quiescence in mammary stem cells and 
breast tumor stem cells: got testable hypotheses? Journal of Mammary Gland 
Biology and Neoplasia, 14(1):19-27. 
 
Harris, M.L., Van den Heuvel, M. R., Rouse, J., Martin, P. A., Struger, J., Bishop, C. A., 
and Takacs, P. (2000). Pesticides in Ontario: A Critical Assessment of Potential 
Toxicity of Agricultural Products to Wildlife, with Consideration for Endocrine 
Disruption. Volume 1: Endosulfan, EBDC fungicides, Dinitroanaline herbicides, 
1,3-Dichloropropene, Azinphos-methyl, and pesticide mixtures. Technical Report 
Series No. 340. Canadian Wildlife Service, Ontario Region. 
 
Hatakeyama, M., Zou, E., and Matsumura, F. (2002). Comparison of the characteristic of 
estrogenic action patterns of beta-HCH and heregulin beta1 in MCF-7 human 





Haynes, D. R., Barg, E., Crotti, T. N., Holding, C., Weedon, H., Atkins, G. J., Zannetino, 
A., Ahern, M. J., Coleman, M., Roberts-Thomson, P. J., Kraan, M., Tak, P. P., 
and Smith, M. D. (2003). Osteoprotegerin expression in synovial tissue from 
patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and 
normal controls. Rheumatology Oxford, 42: 123-134. 
 
Hennighausen, L., and Robinson, G. W. (2001). Signaling pathways in mammary gland 
development. Developmental Cell, 1(4): 467-475. 
 
Herbert, B. M. J., Halsall, C. J., Fitzpatrick, L., Villa, S., Jones, K. C., and Thomas, G. O. 
(2004). Use and validation of novel snow samplers for hydrophobic, semivolatile 
organic compounds (SVOCs). Chemosphere, 56: 227-235. 
 
Hernandez, F., Pitarch, E., Serrano, R., Gaspar, J. V., and Olea, N. (2002). Multiresidue 
determination of endosulfan and metabolic derivatives in human adipose tissue 
using automated liquid chromatographic cleanup and gas chromatographic 
analysis. Journal of Analytical Toxicology, 26(2): 94-103. 
 
Hofbauer, L. C., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., Riggs, B. L., and Khosla, 
S. (1999). Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-
6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. 
Bone, 25: 255-259. 
 
Hofbauer, L. C., Rachner, T., and Singh, S. S. (2008). Fatal attraction: why breast cancer 
cells home to bone. Breast Cancer Research, 10: 101. 
 
Holdway, D. A., Hefferman, J., and Smith, A. (2008). Multigeneration assessment of 
nonylphenol and endosulfan using a model Australian freshwater fish, 
Melanotaenia fluviatilis. Environmental Toxicology, 23(2): 253-62. 
 
Hose, G. C., Lim, R. P., and Hyne, R.V. (2003). The transport, fate and effects of 
endosulfan in the Australian freshwater environment. Australasian Journal of 
Ecotoxicology, 9: 101–111. 
 
Hose, G. C., Lim, R. P., Hyne, R. V., and Pablo, F. (2003). Short-term exposure to 
aqueous endosulfan affects macroinvertebrate assemblages. Ecotoxicology and 
Environmental Safety, 56: 282–94. 
 
Hunter, D. S., Hodges, L. C., Vonier, P. M., Fuchs-Young, R., Gottardis, M. M., and 
Walker, C. L. (1999). Estrogen receptor activation via Activation Function 2 
predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine 
myometrium. Cancer Research, 59: 3090-3099. 
 
Hung, H., Blanchard, P., Halsall, C. J., Bidleman, T. F., Stern, G, A., Fellin, P., Muir, D. 
C., Barrie, L, A., Jantunen, L. M., Helm, P. A., Ma, J., and Konoplev, A. (2005). 
75 
 
Temporal and spatial variabilities of atmospheric polychlorinated biphenyls 
(PCBs), organochlorine (OC) pesticides and polycyclic aromatic hydrocarbons 
(PAHs) in the Canadian Arctic: results from a decade of monitoring. Science of 
the Total Environment, 342(1-3): 119-144. 
 
Ibarluzea, J. J., Fernandez, M. F., Santa-Marina, L., Olea-Serrano, M. F., Rivas, A. M., 
Aurrekoetxea, J. J., Exposito, J., Lorenzo, M., Torne, P., Villalobos, M., Pedraza, 
V., Sasco, A. J., and Olea, N. (2004). Breast cancer risk and the combined effect 
of environmental estrogens. Cancer Causes Control, 15(6): 591-600. 
 
Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010). Cancer statistics, 2010. A Cancer 
Journal for Clinicians, 60(5):277-300. 
 
Jia, Z., and Misra, H. P. (2007a). Exposure to mixtures of endosulfan and zineb induces 
apoptotic and necrotic cell death in SH-SY5Y neuroblastoma cells, in vitro. 
Journal of Applied Toxicology, 27(5): 434-436. 
 
Jia, Z., and Misra, H. P. (2007b). Developmental exposure to pesticides zineb and/or 
endosulfan renders the nigrostriatal dopamine system more susceptible to these 
environmental chemicals later in life. Neurotoxicology, 28(4): 727-735. 
 
Jia, H., Li, Y. F., Wang, D., Cai, D., Yang, M., Ma, J., and Hu, J. (2008). Endosulfan in 
China 1. Gridded Usage Inventories. Enviromental Science and Pollution 
Research. in press. 
 
Johnson, M. G., Kelso, J. R. M., and George, S. E. (1988). Loadings of organochlorine 
contaminants and trace elements to two Ontario lake systems and their 
concentrations in fish. Canadian Journal of Fisheries and Aquatic Sciences, 45: 
170-178. 
 
Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., 
Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., Komnenovic, V., Kong, Y. Y., 
Schreiber, M., Dixon, S. J., Sims, S. M., Khokha, R., Wada, T., and Penninger, J. 
M. (2006). Regulation of cancer cell migration and bone metastasis by RANKL. 
Nature, 440(7084):692-696.  
 
Jonsson, C. M., and Toledo, M. C. F. (1993). Acute toxicity of endosulfan to the fish 
Hyphessobrycon bifasciatus and Brachydanio rerio. Archives of Environmental 
Contamination and Toxicology, 24: 151–155. 
 
Joshi, P. A., Jackson, H. W., Beristain, A. G., Di Grappa, M. A., Mote, P. A., Clarke, C. 
L., Stingl, J., Waterhouse, P. D., and Khokha, R. (2010)Progesterone induces 
adult mammary stem cell expansion. Nature, 465(7299):803-807.  
 
Kannan, K., Holcombe, R. F., Jain, S. K., Alvarez-Hernandez, X., Chervenak, R., Wolf, 
R. E., and Glass, J. (2000). Evidence for the induction of apoptosis by endosulfan 
76 
 
in a human T-cell leukemic line. Molecular and Cellular Biochemistry, 205(1-2): 
53-66. 
 
Karp, Gerald. “Cell and Molecular Biology; Concepts and Experiments.” John Wiley & 
Sons Inc, 2010.  
 
Kidd, H., and James, D. R. (1991). The Agrochemicals Handbook, 3rd Ed. The Royal 
Society of Chemistry, Cambridge UK. 
 
Kishi, M. (2002). Initial Summary of the Main Factors Contributing to Incidents of Acute 
Pesticide Poisoning. Report to IFCS Forum Standing Committee Working Group. 
 
Kojima, H., Katsura, E., Takeuchi, S., Niiyama, K., and Kobayashi, K. (2004). Screening 
for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter 
gene assays using Chinese hamster ovary cells. Environmental Health 
Perspectives, 112(5): 524-531. 
 
Kong, Y. Y., Boyle, W. J., and Penninger, J. M. (1999b). Osteoprotegerin ligand: a 
common link between osteoclastogenesis, lymph node formation and lymphocyte 
development. Immunology and Cell Biology, 77: 188-193. 
 
Kong, Y. Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., 
Elliott, R., McCabe, S., Wong, T., Campagnuolo, G., Moran, E., Bogoch, E. R., 
Van, G., Nguyen, L. T., Ohashi, P. S., Lacey, D. L., Fish, E., Boyle, W. J., and 
Penninger, J. M. (1999a). Activated T cells regulate bone loss and joint 
destruction in adjuvant arthritis through osteoprotegerin ligand. Nature, 402: 304-
309. 
 
Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., 
Furuya, T., Ishiyama, S., Kim, K. J., Saito, S., Nishikawa, T., Takahashi, N., 
Togari, A., Tomatsu, T., Suda, T., and Kamatani, N. (2001). Activated human T 
cells directly induce osteoclastogenesis from human monocytes: possible role of T 
cells in bone destruction in rheumatoid arthritis patients. Arthritis and 
Rheumatism, 44: 1003-1012. 
 
Kumari, B., Madan, V. K., and Kathpal, T. S. (2007). Pesticide residues in rain 
waterfrom Hisar, India. Environmental Monitoring and Assessment, 133: 467-
471. 
 
Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, 
R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., 
Davy, E., Capparelli, C., Eli, A., Qian, Y.-X., Kaufman, S., Sarosi, I., Shalhoub, 
V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. (1998) Osteoprotegerin 





Lafuente, A., Cabaleiro, T., Caride, A., and Romero, A. (2006). Toxic effects of 
endosulfan on blood lymphocyte subset in adult rats. Toxicology Letters,164: 234. 
 
Lau, W. M., Weber, K. L., Doucet, M., Chou, Y.T., Brady, K., Kowalski, J., Tsai, H. L., 
Yang, J. and Kominsky S. L. (2009). Identification of prospective factors 
promoting osteotropism in breast cancer: A potential role for CITED2. Cancer 
Cell Biology, 125: 119-125.   
 
Laville, N., Balguerf, P., Brion, F., Hinfray, N., Casellas, C., Porcher, J. M., and Ait- 
Aissa S. (2006). Modulation of aromatase and mRNA by various selected 
pesticides in the human choriocarcinoma JEG-3 cell line. Toxicology, 228(1): 98-
108. 
 
Ledirac, N., Antherieu, S., d'Uby, A. D., Caron, J. C., and Rahmani, R. (2005). Effects of 
organochlorine insecticides on MAP kinase pathways in human HaCaT 
keratinocytes: key role of reactive oxygen species. Toxicological Sciences, 86(2): 
444-452.  
Lemaire, G., Mnif, W., Mauvais, P., Balaguer, P., and Rahmani, R. (2006). Activation of 
alpha- and beta-estrogen receptors by persistent pesticides in reporter cell lines. 
Life Sciences, 79(12): 1160-1169. 
 
Leonard, A.W., Hyne, R.V., Lim, R. P., Leigh, K. A., Le, J., and Beckett, R. (2001). Fate 
and toxicity of endosulfan in Namoi River water and bottom sediment. Journal of 
Environmental Quality, 30: 750-759. 
 
Li, X., Zhang, S., and Safe, S. (2006). Activation of kinase pathways in MCF-7 cells by 
17B-estradiol and structurally diverse estrogenic compounds. The Journal of 
Steroid Biochemistry and Molecular Biology, 98(2-3): 122-32. 
 
Liu X, Robinson GW, Hennighausen L.(1996). Activation of Stat5a and Stat5b by 
tyrosine phosphorylation is tightly linked to mammary gland differentiation. 
Molecular Endocrinology, 10(12):1496-1506. 
 
Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. 
(1997). Stat5a is mandatory for adult mammary gland development and 
lactogenesis. Genes and Development, 11(2):179-186.  
 
Mariscal-Arcas, M., Lopez-Martinez, C., Granada, A., Olea, N., Lorenzo-Tovar, M. L., 
and Olea-Serrano, F. (2010). Organochlorine pesticides in umbilical cord blood 
serum of women from Southern Spain and adherence to the Mediterranean diet. 
Food and Chemical Toxicology, 48(5): 1311-1315.   
 
Martin, T. J., Romas, E., and Gillespie, M. T. (1998). Interleukins in the control of 





Matthiessen, P. and Logan, J. W. M. (1984). Low concentration effects of endosulfan 
insecticide on reproductive behaviour in the tropical cichlid fish Sarotherodon 
mossambicus. Bulletin of Environmental Contamination and Toxicology, 33: 575-
583. 
 
McClung, M. R. (2006). Inhibition of RANKL as a treatment for osteoporosis: preclinical 
and early clinical studies. Current Osteoporosis Reports, 4(1):28-33. 
 
Mills, P. K., and Yang, R. (2003). Prostate cancer risk in California farm workers. 
Journal of Occupational and Environmental Medicine, 45(3): 249-258 
 
Morony, S., Capparelli, C., Sarosi, I., Lacey. D. L., Dunstan, C. R., and Kostenuik, P. J. 
(2001). Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in 
syngeneic and nude mouse models of experimental bone metastasis. Cancer 
Research, 61(11): 4432-4436.  
 
Mundy, G. R. (2002). Metastasis to bone: causes, consequences and therapeutic 
opportunities. Nature Reviews Cancer, 2(8):584-93. 
 
Nakashima, T., Kobayashi, Y., Yamasaki, S., Kawakami, A., Eguchi, K., Sasaki, H., and 
Sakai, H. (2000). Protein expression and functional difference of membrane-
bound and soluble receptor activator of NF-kappaB ligand: modulation of the 
expression by osteotropic factors and cytokines. Biochemical and Biophysical 
Research Communication, 275: 768-775. 
 
Nakashima, T., Wada, T., and Penninger, J. M. (2003). RANKL and RANK as novel 
therapeutic targets for arthritis. Current Opinion in Rheumatology, 15: 280-287. 
 
Naqvi, S. M., and Vaishnavi, C. (1993). Bioaccumulative potential and toxicity of 
endosulfan insecticide to non-target animals. Comparative Biochemistry and 
Physiology, 105: 347–361. 
 
Okoumassoun, L. E., Averill-Bates, D., Marion, M., and Denizeau, F. (2003). Possible 
mechanisms underlying the mitogenic action of heptachlor in rat hepatocytes. 
Toxicology and Applied Pharmacology, 193: 356–369. 
 
Oktay, C., Goksu, E., Bozdemir, N., and Soyuncu, S. (2003). Unintentional toxicity due 
to endosulfan: a case report of two patients and characteristics of endosulfan 
toxicity. Veterinary and Human Toxicology, 45(6): 318-320. 
 
Pageau, S. C. (2009). Denosumab. MAbs, 1(3): 210-215.   
 
Pagès, G., Guérin, S., Grall, D., Bonino, F., Smith, A., Anjuere, F., Auberger, P., and 
Pouysségur, J. (1999). Defective thymocyte maturation in p44 MAP kinase (Erk 




Paget, S. (1889). The distribution of secondary growths in cancer of the breast. The 
Lancet, 133: 571-573. 
 
Palmer, A., Gavin, A. C. and Nebreda, A. R. (1998). A link between MAP kinase and 
p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and 
inactivates the p34(cdc2) inhibitory kinase Myt1. The EMBO Journal, 17: 5037-
5047.  
 
Pandey, A. C. (1988). Impact of endosulfan (Thiodan) EC 35 on behaviour and dynamics 
of oocyte development in the teleostean fish, Colisa (Trichogaster) fasciatus. 
Ecotoxicology and Environmental Safety, 15: 221-225. 
Reinholz, M. M., Iturria, S. J., Ingle, J. N., and Roche, P. C. (2002). Differential gene 
expression of TGF-beta family members and osteopontin in breast tumor tissue: 
analysis by real-time quantitative PCR. Breast Cancer Research and Treatment, 
74(3): 255-269. 
 
Reuber, M. D. (1981). The role of toxicity in the carcinogenicity of endosulfan. Science 
of the Total Environment, 20(1): 23-47. 
 
Roberts, D. M., Dissanayake, W., Sheriff, M. H. R., and Eddeston, M. (2004). Refractory 
status epilepticus following self-poisoning with the organochlorine pesticide 
endosulfan. Journal of Clinical Neuroscience, 11(7): 760-762. 
 
Ross, F. P. (2000). RANKing the importance of measles in Paget‟s disease. The Journal 
of Clinical Investigation, 105: 555–558. 
 
Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., 
Stefanick, M. L., Jackson, R. D., Berendosulfanord, S. A., Howard, B. V., 
Johnson, K. C., Kotchen, J. M., Ockene, J., and Writing Group for the Women's 
Health Initiative Investigators. (2002). Risks and benefits of estrogen plus 
progestin in healthy postmenopausal women: principal results From the Women's 
Health Initiative randomized controlled trial. The Journal of the American 
Medical Association, 288(3):321-333. 
 
Rousseau, J., Cossette, L., Grenier, S., and Martinoli, M. G. (2002). Modulation of 
prolactin expression by xenoestrogens. General and Comparitive Endocrinology, 
126(2): 175-182. 
 
Rupa, D. S., Reddy, P. P., and Reddi, O. S. (1991). Reproductive performance in 
population exposed to pesticides in cotton fields in India. Environmental 
Research, 55(2): 123-128. 
 
Saiyed, H., Dewan, A., Bhatnagar, V., Shenoy, U., Shenoy, R., Rajmohan, H., Patel, K., 
Kashyap, R., Kulkarni, P., Rajan, B., and Lakkad, B. (2003). Effect of endosulfan 





Schramek, D., Leibbrandt, A., Sigl, V., Kenner, L., Pospisilik, J. A., Lee, H. J., Hanada, 
R., Joshi, P. A., Aliprantis, A., Glimcher, L., Pasparakis, M., Khokha, R., 
Ormandy, C. J., Widschwendter, M., Schett, G., and Penninger, J. M. (2010). 
Osteoclast differentiation factor RANKL controls development of progestin-
driven mammary cancer. Nature, 468(7320): 98-102  
 
Schramek, H. (2002). MAP kinases: from intracellular signals to physiology and disease. 
News in Physiological Sciences, 17: 62-67.  
 
Schulz, R. (2004). Field studies on exposure, effects, and risk mitigation of aquatic 
nonpoint-source insecticide pollution: a review. Journal of Environmental 
Quality, 33(2): 419-48. 
 
Scippo, M. L., Argiris, C., Van De Weerdt, C., Muller, M., Willemsen, P., Martial, J., and 
Maghuin-Rogister, G. (2004). Recombinant human estrogen, androgen and 
progesterone receptors for detection of potential endocrine disruptors. Analytical 
and Bioanalytical Chemistry, 378(3): 664-669.  
 
Shaul, Y. D., and Seger, R. (2007). The MEK/ERK cascade: from signaling specificity to 
diverse functions. Biochimica et Biophysica Acta, 1773(8):1213-1226. 
 
Shackleton, M., Vaillant, F., Simpson, K. J., Stingl, J., Smyth, G. K., Asselin-Labat, M. 
L., Wu, L., Lindeman, G. J., and Visvader, J. E. (2006). Generation of a 
functional mammary gland from a single stem cell. Nature, 439(7072):84-88.  
 
Shen, Y., Luche, R., Wei, B., Gordon, M. L., Diltz, C. D., and Tonks, N. K. (2001). 
Activation of the Jnk signaling pathway by a dual-specificity phosphatase, JSP-1. 
Proceedings of the Natural Academy of Sciences of the United States of America, 
98(24): 13613-13618. 
 
Simonet, W. S., Lacey, D. L., and Dunstan, C. R. (1997). Osteoprotegerin: a novel 
secreted protein involved in the regulation of bone density. Cell, 89: 309-19.  
 
Sinha, N., Adhikari, N., and Saxena, D. K. (2001). Effect of endosulfan during gonadal 
differentiation on spermatogenesis in rats. Environmental Toxicology and 
Pharmacology, 10: 29-32. 
 
Sloan, E. K., and Anderson, R. L. (2002). Genes involved in breast cancer metastasis to 
bone. Cellular and Molecular Life Sciences, 59(9):1491-502. 
 





Soto, A. M., Chung, K. L., and Sonnenschein, C. (1994). The pesticides endosulfan, 
toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. 
Environmental Health Perspectives, 102: 380-383. 
 
Soto, A. M., Sonnenschein, C., Chung, K. L., Fernandez, M. F., Olea, N., and Serrano F. 
O. (1995). The E-SCREEN assay as a tool to identify estrogens: an update on 
estrogenic environmental pollutants. Environmental Health Perspectives, 103: 
113–122. 
 
Srikanth, N. S., Seth, P. K., and Desaiah, D. (1989). Inhibition of calmodulin-activated 
Ca2--ATPase by endosulfan in rat brain. Journal of Toxicology and 
Environmental Health, 28: 473-481. 
 
Srivastava, S., Matsuda, M., Hou, Z., Bailey, J. P., Kitazawa, R., Herbst, M. P., and 
Horseman N. D. (2003). Receptor activator of NF-kappaB ligand induction via 
Jak2 and Stat5a in mammary epithelial cells. The Journal of Biological 
Chemistry, 278(46): 46171-46178. 
 
Stopeck, A. T., Lipton, A., Body, J. J., Steger, G. G., Tonkin, K., de Boer, R. H., 
Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., Fan, M., Jiang, Q., 
Dansey, R., Jun, S., and Braun, A. (2010). Denosumab compared with zoledronic 
acid for the treatment of bone metastases in patients with advanced breast cancer: 
a randomized, double-blind study. Journal of Clinical Oncology, 28(35): 5132-
5139.  
 
Sutherland, T. D., Home, I., Weir, K. M., Russell, R. J., and Oakeshott, J. G. (2004). 
Toxicity and residues of endosulfan isomers. Reviews of Environmental 
Contamination and Toxicology, 183: 99-113. 
 
Suzuki, J., Ikeda, T., Kuroyama, H., Seki, S., Kasai, M., Utsuyama, M., Tatsumi, M., 
Uematsu, H., and Hirokawa, K. (2004). Regulation of osteoclastogenesis by three 
human RANKL isoforms expressed in NIH3T3 cells. Biochemical and 
Biophysical Research Communication, 314(4):1021-7. 
 
Takahashi, N., Udagawa, N., and Suda, T. (1999). A new member of tumor necrosis 
factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast 
differentiation and function. Biochemical and Biophysical Research 
Communication, 256: 4449-55. 
 
Tamura, K., Sudo, T., Senftleben, U., Dadak, A. M., Johnson, R., and Karin, M. (2000). 
Requirement for p38a in erythropoietin expression: A role for stress kinases in 
erythropoiesis. Cell, 102: 221-231. 
 
Tariq, M. I., Afzal, S., and Hussain, I. (2004). Pesticides in shallow groundwater of 
Bahawalnagar, Muzafargarh, D.G. Khan and Rajan Pur districts of Punjab, 




Theill, L. E., Boyle, W. J., and Penninger, J. M. (2002). RANK-L and RANK: T cells, 
bone loss, and mammalian evolution. Annual Review of Immunology, 20: 795-
823. 
 
Toppari, J., Larsen, J. P., Christiansen, A., Giwercman, P. G., Guillette, L. J., Jegou, B., 
Jensen, T.K., Jouannet, P., Keiding, N., Leffers, H., McLachlan, J.A., Meyer, O., 
Muller, J., Rajpert-De Meyts, E., Scheike, T., Sharpe, R., Sumpter, J., and 
Skakkebaek, N. E. (1996). Male Reproductive Health and Environmental 
Xenoestrogens. Environmental Health Perspectives, 104(4): 741-803 
 
Tournier, C., Hess, P., Yang, D. D., Xu, J., Turner, T. K., Nimnual, A., Bar-Sagi, D., 
Jones, S. N., Flavell, R. A., and Davis, R. J. (2000). Requirement of JNK for 
stress-induced activation of the cytochrome c-mediated death pathway. Science, 
288: 870-874. 
  
Treinies, I., Paterson, H. F., Hooper, S., Wilson, R. and Marshall, C. J. (1999). Activated 
MEK stimulates expression of AP-1 components independently of 
phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to 
stimulate DNA synthesis. Molecular and Cellular Biology, 19: 321-329. 
 
Trichopoulos, D., MacMahon, B., and Cole, P. (1972). Menopause and breast cancer risk. 
Journal of the National Cancer Institute, 48(3):605-13.  
 
Tuduri, L., Harner, T., Blanchard, P., Li, Y. F., Poissant, L., Waite, D. T., Murphy, C., 
and Belzer, W. (2006). A review of currently used pesticides (CUPs) in Canadian 
air and precipitation: Part 1: Lindane and endosulfans. Atmospheric Environment, 
40: 1563-1578. 
 
Turusov, V., Rakitsky, V., and Tomatis, L. (2002). 
Dichlorodiphenyltrichloroethane IDDTI: ubiquity, persistence, and risks. 
Environmental Health Perspectives, 110: 125-128. 
 
Vidal, J. M., Gonzalez, F. E., Frenich, A. G., Galera, M. M., Aguilera, P. A., and 
Carrique, E. L. (2002). Assessment of relevant factors and relationships 
concerning human dermal exposure to pesticides in greenhouse 
applications. Pest Management Science, 58(8): 784-790.  
 
Vidal, O. N., Sjogren, K., Eriksson, B. I., Ljunggren, O., and Ohlsson, C. (1998) 
Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human 
osteosarcoma cell line MG-63 and in human osteoblast-like cells. Biochemical 
and Biophysical Research Communication, 248: 696-700. 
 
Vorkamp, K., Riget, F., Glasius, M., Pecseli, M., Lebeuf, M., and Muir, D. (2004). 
Chlorobenzenes, chlorinated pesticides, coplanar chlorobiphenyls and other 





Wan, M. T., Kuo, J. N., and Pasternak, J. (2005a). Residues of endosulfan and other 
selected organochlorine pesticides in farm areas of the Lower Fraser Valley, 
British Columbia, Canada. Journal of Environmental Quality, 34(4): 1186-1193.  
 
Wan, M.T., Kuo J. N., Buday, C., Schroeder, G., Aggelen, G. V., and Pasternak, J. 
(2005b).Toxicity of α- and β-endosulfan and their formulated and degradation 
products to Daphnia magna, Hyalella azteca, Oncorhynchus mykiss, 
Oncorhynchus kisutch, and biological implications in streams. Environmental 
Toxicology and Chemistry, 24:1146–1154. 
 
Wang, X. F., Li, S., Chou, A. P., and Bronstein, J. M. (2006a). Inhibitory effects of 
pesticides on proteasome activity: implication in Parkinson‟s disease. 
Neurobiology of Disease, 23(1): 198-205. 
 
Warngard, I., Bager, Y., Kato, Y., Kenne, K., and Ahlborg, U. G. (1996). Mechanistical 
studies of the inhibition of intercellular communication by organochlorine 
compounds. Archives of Toxicology Supplement, 18:149-159. 
 
Watson, C., Bulayeva, N. N., Wozniak, A. L., and Alyea, R. A. (2007). Xenoestrogens 
are potent activators of nongenomic estrogenic responses. Steroids, 72: 124-34. 
 
Wei, S., Teitebaum, S. L., Wang, M. W. H. and Ross F. P. (2001). Receptor activator of 
nuclear factor – kB in osteoclast recursors. Endocrinology, 142: 1290-1295. 
 
Weiderpass, E., Adami, H. O., Baron, J. A., Wicklund-Glynn, A., Aune, M., Atuma, S., 
and Persson, I. (2000). Organochlorines and endometrial cancer risk. Cancer 
Epidemiology, Biomarkers and Prevention, 9(5): 487-493. 
 
Wesseling, C., Corriols, M., and Bravo, V. (2005). Acute pesticide poisoning and 
pesticide registration in Central America. Toxicology and Applied Pharmacology, 
207: 697-705. 
 
Wong, B. R., Rho, J., Arron, J., Robinson, E., Orlinick, J., Chao, M., Kalachikov, S., 
Cayani, E., Bartlett, F. S., Frankel, W. N., Lee, S. Y., and Choi, Y. (1997). 
TRANCE is a novel ligand of the tumor necrosis factor receptor family that 
activates c-Jun N-terminal kinase in T cells. The Journal of Biological Chemistry, 
272: 25190–25194.  
 
Wong, P. S., and Matsumura, F. (2006). Serum free BG-1 cell proliferation assay: a 
sensitive method for determining organochlorine pesticide estrogen receptor 
activation at the nanomolar range. Toxicology In Vitro, 20(3): 382-394. 
 
Wozniak, A. L., Bulayeva, N. N., and Watson, C. S. (2005). Xenoestrogens at picomolar 
to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated 
Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Environmental 




Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J. and Greenberg, M. E. (1995). Opposing 
effects of ERK and JNKp38 MAP kinases on apoptosis. Science, 270: 1326-1331  
 
Yang, D. D., Conze, D., Whitmarsh, A. J., Barrett, T., Davis, R. J., Rincón, M., and 
Flavell, R. A. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase 
JNK2. Immunity, 9(4):575-585. 
 
Yang, D. D., Kuan, C. Y., Whitmarsh, A. J., Rincón, M., Zheng, T. S., Davis, R. J., 
Rakic, P., and Flavell, R. A. (1997). Absence of excitotoxicity-induced apoptosis 
in the hippocampus of mice lacking the Jnk3 gene. Nature, 389: 865-870. 
 
Yao, Y., Tuduri, L., Harner, T., Blanchard, P., Waite, D., Poissant, L., Murphy, C., 
Belzer, W., Aulagnier, F., Li, Y. F., and Sverko, E. (2006). Spatial and temporal 
distribution of pesticide air concentrations in Canadian agricultural regions. 
Atmospheric Environment, 40: 4339-4351. 
 
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S., 
Tomoyasu, A., Yano, K., Goto, M., Murakami, A., Tsuda, E., Morinaga, T., 
Higashio, K., Udagawa, N., Takahashi, N., and Suda, T. (1998). Osteoclast 
differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory 
factor and is identical to TRANCE/RANKL. Proceedings of the Natural Academy 
of Sciences of the United States of America, 95: 3597-3602. 
 
Yu, Q., Geng, Y., and Sicinski, P. (2001). Specific protection against breast cancers by 
cyclin D1 ablation. Nature, 411(6841): 1017-1021.  
 
Zhou, S., Yuan, X., Liu, Q., Zhang, X., Pan, X., Zang, L., and Xu, L. (2010). BAPTA-
AM, an intracellular calcium chelator, inhibits RANKL-induced bone marrow 
macrophages differentiation through MEK/ERK, p38 MAPK and Akt, but not 
JNK pathways. Cytokine, 52(3): 210-214.  
 
 
